{
    "atc": [
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA07",
            "who_name": "levonorgestrel and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA08",
            "who_name": "medroxyprogesterone and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA09",
            "who_name": "desogestrel and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA10",
            "who_name": "gestodene and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA11",
            "who_name": "norgestimate and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA12",
            "who_name": "drospirenone and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA13",
            "who_name": "norelgestromin and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA14",
            "who_name": "nomegestrol and estradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA15",
            "who_name": "chlormadinone and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA16",
            "who_name": "dienogest and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA17",
            "who_name": "medroxyprogesterone and estradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03AA18",
            "who_name": "drospirenone and estetrol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03AB01",
            "who_name": "megestrol and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03AB02",
            "who_name": "lynestrenol and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03AB03",
            "who_name": "levonorgestrel and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03AB04",
            "who_name": "norethisterone and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03AB05",
            "who_name": "desogestrel and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03AB06",
            "who_name": "gestodene and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03AB07",
            "who_name": "chlormadinone and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03AB08",
            "who_name": "dienogest and estradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03AB09",
            "who_name": "norgestimate and ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AC",
            "level4_description": "Progestogens",
            "level5": "G03AC01",
            "who_name": "norethisterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AC",
            "level4_description": "Progestogens",
            "level5": "G03AC02",
            "who_name": "lynestrenol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AC",
            "level4_description": "Progestogens",
            "level5": "G03AC03",
            "who_name": "levonorgestrel"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AC",
            "level4_description": "Progestogens",
            "level5": "G03AC04",
            "who_name": "quingestanol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AC",
            "level4_description": "Progestogens",
            "level5": "G03AC05",
            "who_name": "megestrol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AC",
            "level4_description": "Progestogens",
            "level5": "G03AC06",
            "who_name": "medroxyprogesterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AC",
            "level4_description": "Progestogens",
            "level5": "G03AC07",
            "who_name": "norgestrienone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AC",
            "level4_description": "Progestogens",
            "level5": "G03AC08",
            "who_name": "etonogestrel"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AC",
            "level4_description": "Progestogens",
            "level5": "G03AC09",
            "who_name": "desogestrel"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AC",
            "level4_description": "Progestogens",
            "level5": "G03AC10",
            "who_name": "drospirenone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AD",
            "level4_description": "Emergency contraceptives",
            "level5": "G03AD01",
            "who_name": "levonorgestrel"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03A",
            "level3_description": "HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE",
            "level4": "G03AD",
            "level4_description": "Emergency contraceptives",
            "level5": "G03AD02",
            "who_name": "ulipristal"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03B",
            "level3_description": "ANDROGENS",
            "level4": "G03BA",
            "level4_description": "3-oxoandrosten (4) derivatives",
            "level5": "G03BA01",
            "who_name": "fluoxymesterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03B",
            "level3_description": "ANDROGENS",
            "level4": "G03BA",
            "level4_description": "3-oxoandrosten (4) derivatives",
            "level5": "G03BA02",
            "who_name": "methyltestosterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03B",
            "level3_description": "ANDROGENS",
            "level4": "G03BA",
            "level4_description": "3-oxoandrosten (4) derivatives",
            "level5": "G03BA03",
            "who_name": "testosterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03B",
            "level3_description": "ANDROGENS",
            "level4": "G03BB",
            "level4_description": "5-androstanon (3) derivatives",
            "level5": "G03BB01",
            "who_name": "mesterolone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03B",
            "level3_description": "ANDROGENS",
            "level4": "G03BB",
            "level4_description": "5-androstanon (3) derivatives",
            "level5": "G03BB02",
            "who_name": "androstanolone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CA",
            "level4_description": "Natural and semisynthetic estrogens, plain",
            "level5": "G03CA01",
            "who_name": "ethinylestradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CA",
            "level4_description": "Natural and semisynthetic estrogens, plain",
            "level5": "G03CA03",
            "who_name": "estradiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CA",
            "level4_description": "Natural and semisynthetic estrogens, plain",
            "level5": "G03CA04",
            "who_name": "estriol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CA",
            "level4_description": "Natural and semisynthetic estrogens, plain",
            "level5": "G03CA06",
            "who_name": "chlorotrianisene"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CA",
            "level4_description": "Natural and semisynthetic estrogens, plain",
            "level5": "G03CA07",
            "who_name": "estrone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CA",
            "level4_description": "Natural and semisynthetic estrogens, plain",
            "level5": "G03CA09",
            "who_name": "promestriene"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CA",
            "level4_description": "Natural and semisynthetic estrogens, plain",
            "level5": "G03CA53",
            "who_name": "estradiol, combinations"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CA",
            "level4_description": "Natural and semisynthetic estrogens, plain",
            "level5": "G03CA57",
            "who_name": "conjugated estrogens"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CB",
            "level4_description": "Synthetic estrogens, plain",
            "level5": "G03CB01",
            "who_name": "dienestrol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CB",
            "level4_description": "Synthetic estrogens, plain",
            "level5": "G03CB02",
            "who_name": "diethylstilbestrol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CB",
            "level4_description": "Synthetic estrogens, plain",
            "level5": "G03CB03",
            "who_name": "methallenestril"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CB",
            "level4_description": "Synthetic estrogens, plain",
            "level5": "G03CB04",
            "who_name": "moxestrol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CC",
            "level4_description": "Estrogens, combinations with other drugs",
            "level5": "G03CC02",
            "who_name": "dienestrol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CC",
            "level4_description": "Estrogens, combinations with other drugs",
            "level5": "G03CC03",
            "who_name": "methallenestril"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CC",
            "level4_description": "Estrogens, combinations with other drugs",
            "level5": "G03CC04",
            "who_name": "estrone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CC",
            "level4_description": "Estrogens, combinations with other drugs",
            "level5": "G03CC05",
            "who_name": "diethylstilbestrol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CC",
            "level4_description": "Estrogens, combinations with other drugs",
            "level5": "G03CC06",
            "who_name": "estriol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CC",
            "level4_description": "Estrogens, combinations with other drugs",
            "level5": "G03CC07",
            "who_name": "conjugated estrogens and bazedoxifene"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03C",
            "level3_description": "ESTROGENS",
            "level4": "G03CX",
            "level4_description": "Other estrogens",
            "level5": "G03CX01",
            "who_name": "tibolone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DA",
            "level4_description": "Pregnen (4) derivatives",
            "level5": "G03DA01",
            "who_name": "gestonorone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DA",
            "level4_description": "Pregnen (4) derivatives",
            "level5": "G03DA02",
            "who_name": "medroxyprogesterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DA",
            "level4_description": "Pregnen (4) derivatives",
            "level5": "G03DA03",
            "who_name": "hydroxyprogesterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DA",
            "level4_description": "Pregnen (4) derivatives",
            "level5": "G03DA04",
            "who_name": "progesterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DB",
            "level4_description": "Pregnadien derivatives",
            "level5": "G03DB01",
            "who_name": "dydrogesterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DB",
            "level4_description": "Pregnadien derivatives",
            "level5": "G03DB02",
            "who_name": "megestrol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DB",
            "level4_description": "Pregnadien derivatives",
            "level5": "G03DB03",
            "who_name": "medrogestone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DB",
            "level4_description": "Pregnadien derivatives",
            "level5": "G03DB04",
            "who_name": "nomegestrol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DB",
            "level4_description": "Pregnadien derivatives",
            "level5": "G03DB05",
            "who_name": "demegestone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DB",
            "level4_description": "Pregnadien derivatives",
            "level5": "G03DB06",
            "who_name": "chlormadinone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DB",
            "level4_description": "Pregnadien derivatives",
            "level5": "G03DB07",
            "who_name": "promegestone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DB",
            "level4_description": "Pregnadien derivatives",
            "level5": "G03DB08",
            "who_name": "dienogest"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DC",
            "level4_description": "Estren derivatives",
            "level5": "G03DC01",
            "who_name": "allylestrenol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DC",
            "level4_description": "Estren derivatives",
            "level5": "G03DC02",
            "who_name": "norethisterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DC",
            "level4_description": "Estren derivatives",
            "level5": "G03DC03",
            "who_name": "lynestrenol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DC",
            "level4_description": "Estren derivatives",
            "level5": "G03DC04",
            "who_name": "ethisterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DC",
            "level4_description": "Estren derivatives",
            "level5": "G03DC06",
            "who_name": "etynodiol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03D",
            "level3_description": "PROGESTOGENS",
            "level4": "G03DC",
            "level4_description": "Estren derivatives",
            "level5": "G03DC31",
            "who_name": "methylestrenolone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03E",
            "level3_description": "ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION",
            "level4": "G03EA",
            "level4_description": "Androgens and estrogens",
            "level5": "G03EA01",
            "who_name": "methyltestosterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03E",
            "level3_description": "ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION",
            "level4": "G03EA",
            "level4_description": "Androgens and estrogens",
            "level5": "G03EA02",
            "who_name": "testosterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03E",
            "level3_description": "ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION",
            "level4": "G03EA",
            "level4_description": "Androgens and estrogens",
            "level5": "G03EA03",
            "who_name": "prasterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03E",
            "level3_description": "ANDROGENS AND FEMALE SEX HORMONES IN COMBINATION",
            "level4": "G03EK",
            "level4_description": "Androgens and female sex hormones in combination with other drugs",
            "level5": "G03EK01",
            "who_name": "methyltestosterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA01",
            "who_name": "norethisterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA02",
            "who_name": "hydroxyprogesterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA03",
            "who_name": "ethisterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA04",
            "who_name": "progesterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA05",
            "who_name": "methylnortestosterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA06",
            "who_name": "etynodiol and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA07",
            "who_name": "lynestrenol and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA08",
            "who_name": "megestrol and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA09",
            "who_name": "noretynodrel and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA10",
            "who_name": "norgestrel and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA11",
            "who_name": "levonorgestrel and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA12",
            "who_name": "medroxyprogesterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA13",
            "who_name": "norgestimate and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA14",
            "who_name": "dydrogesterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA15",
            "who_name": "dienogest and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA16",
            "who_name": "trimegestone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FA",
            "level4_description": "Progestogens and estrogens, fixed combinations",
            "level5": "G03FA17",
            "who_name": "drospirenone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03FB01",
            "who_name": "norgestrel and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03FB02",
            "who_name": "lynestrenol and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03FB03",
            "who_name": "chlormadinone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03FB04",
            "who_name": "megestrol and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03FB05",
            "who_name": "norethisterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03FB06",
            "who_name": "medroxyprogesterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03FB07",
            "who_name": "medrogestone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03FB08",
            "who_name": "dydrogesterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03FB09",
            "who_name": "levonorgestrel and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03FB10",
            "who_name": "desogestrel and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03FB11",
            "who_name": "trimegestone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03F",
            "level3_description": "PROGESTOGENS AND ESTROGENS IN COMBINATION",
            "level4": "G03FB",
            "level4_description": "Progestogens and estrogens, sequential preparations",
            "level5": "G03FB12",
            "who_name": "nomegestrol and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GA",
            "level4_description": "Gonadotropins",
            "level5": "G03GA01",
            "who_name": "chorionic gonadotrophin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GA",
            "level4_description": "Gonadotropins",
            "level5": "G03GA02",
            "who_name": "human menopausal gonadotrophin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GA",
            "level4_description": "Gonadotropins",
            "level5": "G03GA03",
            "who_name": "serum gonadotrophin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GA",
            "level4_description": "Gonadotropins",
            "level5": "G03GA04",
            "who_name": "urofollitropin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GA",
            "level4_description": "Gonadotropins",
            "level5": "G03GA05",
            "who_name": "follitropin alfa"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GA",
            "level4_description": "Gonadotropins",
            "level5": "G03GA06",
            "who_name": "follitropin beta"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GA",
            "level4_description": "Gonadotropins",
            "level5": "G03GA07",
            "who_name": "lutropin alfa"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GA",
            "level4_description": "Gonadotropins",
            "level5": "G03GA08",
            "who_name": "choriogonadotropin alfa"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GA",
            "level4_description": "Gonadotropins",
            "level5": "G03GA09",
            "who_name": "corifollitropin alfa"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GA",
            "level4_description": "Gonadotropins",
            "level5": "G03GA10",
            "who_name": "follitropin delta"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GA",
            "level4_description": "Gonadotropins",
            "level5": "G03GA30",
            "who_name": "combinations"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GB",
            "level4_description": "Ovulation stimulants, synthetic",
            "level5": "G03GB01",
            "who_name": "cyclofenil"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GB",
            "level4_description": "Ovulation stimulants, synthetic",
            "level5": "G03GB02",
            "who_name": "clomifene"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03G",
            "level3_description": "GONADOTROPINS AND OTHER OVULATION STIMULANTS",
            "level4": "G03GB",
            "level4_description": "Ovulation stimulants, synthetic",
            "level5": "G03GB03",
            "who_name": "epimestrol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03H",
            "level3_description": "ANTIANDROGENS",
            "level4": "G03HA",
            "level4_description": "Antiandrogens, plain",
            "level5": "G03HA01",
            "who_name": "cyproterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03H",
            "level3_description": "ANTIANDROGENS",
            "level4": "G03HB",
            "level4_description": "Antiandrogens and estrogens",
            "level5": "G03HB01",
            "who_name": "cyproterone and estrogen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03X",
            "level3_description": "OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level4": "G03XA",
            "level4_description": "Antigonadotropins and similar agents",
            "level5": "G03XA01",
            "who_name": "danazol"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03X",
            "level3_description": "OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level4": "G03XA",
            "level4_description": "Antigonadotropins and similar agents",
            "level5": "G03XA02",
            "who_name": "gestrinone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03X",
            "level3_description": "OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level4": "G03XB",
            "level4_description": "Progesterone receptor modulators",
            "level5": "G03XB01",
            "who_name": "mifepristone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03X",
            "level3_description": "OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level4": "G03XB",
            "level4_description": "Progesterone receptor modulators",
            "level5": "G03XB02",
            "who_name": "ulipristal"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03X",
            "level3_description": "OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level4": "G03XB",
            "level4_description": "Progesterone receptor modulators",
            "level5": "G03XB51",
            "who_name": "mifepristone, combinations"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03X",
            "level3_description": "OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level4": "G03XC",
            "level4_description": "Selective estrogen receptor modulators",
            "level5": "G03XC01",
            "who_name": "raloxifene"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03X",
            "level3_description": "OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level4": "G03XC",
            "level4_description": "Selective estrogen receptor modulators",
            "level5": "G03XC02",
            "who_name": "bazedoxifene"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03X",
            "level3_description": "OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level4": "G03XC",
            "level4_description": "Selective estrogen receptor modulators",
            "level5": "G03XC03",
            "who_name": "lasofoxifene"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03X",
            "level3_description": "OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level4": "G03XC",
            "level4_description": "Selective estrogen receptor modulators",
            "level5": "G03XC04",
            "who_name": "ormeloxifene"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03X",
            "level3_description": "OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level4": "G03XC",
            "level4_description": "Selective estrogen receptor modulators",
            "level5": "G03XC05",
            "who_name": "ospemifene"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G03",
            "level2_description": "SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level3": "G03X",
            "level3_description": "OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM",
            "level4": "G03XX",
            "level4_description": "Other sex hormones and modulators of the genital system",
            "level5": "G03XX01",
            "who_name": "prasterone"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BA",
            "level4_description": "Acidifiers",
            "level5": "G04BA01",
            "who_name": "ammonium chloride"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BA",
            "level4_description": "Acidifiers",
            "level5": "G04BA03",
            "who_name": "calcium chloride"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD01",
            "who_name": "emepronium"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD02",
            "who_name": "flavoxate"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD03",
            "who_name": "meladrazine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD04",
            "who_name": "oxybutynin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD05",
            "who_name": "terodiline"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD06",
            "who_name": "propiverine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD07",
            "who_name": "tolterodine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD08",
            "who_name": "solifenacin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD09",
            "who_name": "trospium"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD10",
            "who_name": "darifenacin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD11",
            "who_name": "fesoterodine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD12",
            "who_name": "mirabegron"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BD",
            "level4_description": "Drugs for urinary frequency and incontinence",
            "level5": "G04BD13",
            "who_name": "desfesoterodine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BE",
            "level4_description": "Drugs used in erectile dysfunction",
            "level5": "G04BE01",
            "who_name": "alprostadil"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BE",
            "level4_description": "Drugs used in erectile dysfunction",
            "level5": "G04BE02",
            "who_name": "papaverine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BE",
            "level4_description": "Drugs used in erectile dysfunction",
            "level5": "G04BE03",
            "who_name": "sildenafil"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BE",
            "level4_description": "Drugs used in erectile dysfunction",
            "level5": "G04BE04",
            "who_name": "yohimbine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BE",
            "level4_description": "Drugs used in erectile dysfunction",
            "level5": "G04BE06",
            "who_name": "moxisylyte"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BE",
            "level4_description": "Drugs used in erectile dysfunction",
            "level5": "G04BE07",
            "who_name": "apomorphine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BE",
            "level4_description": "Drugs used in erectile dysfunction",
            "level5": "G04BE08",
            "who_name": "tadalafil"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BE",
            "level4_description": "Drugs used in erectile dysfunction",
            "level5": "G04BE09",
            "who_name": "vardenafil"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BE",
            "level4_description": "Drugs used in erectile dysfunction",
            "level5": "G04BE10",
            "who_name": "avanafil"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BE",
            "level4_description": "Drugs used in erectile dysfunction",
            "level5": "G04BE11",
            "who_name": "udenafil"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BE",
            "level4_description": "Drugs used in erectile dysfunction",
            "level5": "G04BE30",
            "who_name": "combinations"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BE",
            "level4_description": "Drugs used in erectile dysfunction",
            "level5": "G04BE52",
            "who_name": "papaverine, combinations"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BX",
            "level4_description": "Other urologicals",
            "level5": "G04BX01",
            "who_name": "magnesium hydroxide"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BX",
            "level4_description": "Other urologicals",
            "level5": "G04BX03",
            "who_name": "acetohydroxamic acid"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BX",
            "level4_description": "Other urologicals",
            "level5": "G04BX06",
            "who_name": "phenazopyridine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BX",
            "level4_description": "Other urologicals",
            "level5": "G04BX10",
            "who_name": "succinimide"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BX",
            "level4_description": "Other urologicals",
            "level5": "G04BX11",
            "who_name": "collagen"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BX",
            "level4_description": "Other urologicals",
            "level5": "G04BX12",
            "who_name": "phenyl salicylate"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BX",
            "level4_description": "Other urologicals",
            "level5": "G04BX13",
            "who_name": "dimethyl sulfoxide"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BX",
            "level4_description": "Other urologicals",
            "level5": "G04BX14",
            "who_name": "dapoxetine"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BX",
            "level4_description": "Other urologicals",
            "level5": "G04BX15",
            "who_name": "pentosan polysulfate sodium"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04B",
            "level3_description": "UROLOGICALS",
            "level4": "G04BX",
            "level4_description": "Other urologicals",
            "level5": "G04BX16",
            "who_name": "tiopronin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "G04CA01",
            "who_name": "alfuzosin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "G04CA02",
            "who_name": "tamsulosin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "G04CA03",
            "who_name": "terazosin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "G04CA04",
            "who_name": "silodosin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "G04CA51",
            "who_name": "alfuzosin and finasteride"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "G04CA52",
            "who_name": "tamsulosin and dutasteride"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "G04CA53",
            "who_name": "tamsulosin and solifenacin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CA",
            "level4_description": "Alpha-adrenoreceptor antagonists",
            "level5": "G04CA54",
            "who_name": "tamsulosin and tadalafil"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CB",
            "level4_description": "Testosterone-5-alpha reductase inhibitors",
            "level5": "G04CB01",
            "who_name": "finasteride"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CB",
            "level4_description": "Testosterone-5-alpha reductase inhibitors",
            "level5": "G04CB02",
            "who_name": "dutasteride"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CX",
            "level4_description": "Other drugs used in benign prostatic hypertrophy",
            "level5": "G04CX01",
            "who_name": "Prunus africanae cortex"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CX",
            "level4_description": "Other drugs used in benign prostatic hypertrophy",
            "level5": "G04CX02",
            "who_name": "Sabalis serrulatae fructus"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CX",
            "level4_description": "Other drugs used in benign prostatic hypertrophy",
            "level5": "G04CX03",
            "who_name": "mepartricin"
        },
        {
            "level1": "G",
            "level1_description": "GENITO URINARY SYSTEM AND SEX HORMONES",
            "level2": "G04",
            "level2_description": "UROLOGICALS",
            "level3": "G04C",
            "level3_description": "DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY",
            "level4": "G04CX",
            "level4_description": "Other drugs used in benign prostatic hypertrophy",
            "level5": "G04CX04",
            "who_name": "fexapotide"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01A",
            "level3_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
            "level4": "H01AA",
            "level4_description": "ACTH",
            "level5": "H01AA01",
            "who_name": "corticotropin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01A",
            "level3_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
            "level4": "H01AA",
            "level4_description": "ACTH",
            "level5": "H01AA02",
            "who_name": "tetracosactide"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01A",
            "level3_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
            "level4": "H01AB",
            "level4_description": "Thyrotropin",
            "level5": "H01AB01",
            "who_name": "thyrotropin alfa"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01A",
            "level3_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
            "level4": "H01AC",
            "level4_description": "Somatropin and somatropin agonists",
            "level5": "H01AC01",
            "who_name": "somatropin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01A",
            "level3_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
            "level4": "H01AC",
            "level4_description": "Somatropin and somatropin agonists",
            "level5": "H01AC02",
            "who_name": "somatrem"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01A",
            "level3_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
            "level4": "H01AC",
            "level4_description": "Somatropin and somatropin agonists",
            "level5": "H01AC03",
            "who_name": "mecasermin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01A",
            "level3_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
            "level4": "H01AC",
            "level4_description": "Somatropin and somatropin agonists",
            "level5": "H01AC04",
            "who_name": "sermorelin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01A",
            "level3_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
            "level4": "H01AC",
            "level4_description": "Somatropin and somatropin agonists",
            "level5": "H01AC05",
            "who_name": "mecasermin rinfabate"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01A",
            "level3_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
            "level4": "H01AC",
            "level4_description": "Somatropin and somatropin agonists",
            "level5": "H01AC06",
            "who_name": "tesamorelin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01A",
            "level3_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
            "level4": "H01AC",
            "level4_description": "Somatropin and somatropin agonists",
            "level5": "H01AC07",
            "who_name": "somapacitan"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01A",
            "level3_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
            "level4": "H01AC",
            "level4_description": "Somatropin and somatropin agonists",
            "level5": "H01AC08",
            "who_name": "somatrogon"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01A",
            "level3_description": "ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES",
            "level4": "H01AX",
            "level4_description": "Other anterior pituitary lobe hormones and analogues",
            "level5": "H01AX01",
            "who_name": "pegvisomant"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01B",
            "level3_description": "POSTERIOR PITUITARY LOBE HORMONES",
            "level4": "H01BA",
            "level4_description": "Vasopressin and analogues",
            "level5": "H01BA01",
            "who_name": "vasopressin (argipressin)"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01B",
            "level3_description": "POSTERIOR PITUITARY LOBE HORMONES",
            "level4": "H01BA",
            "level4_description": "Vasopressin and analogues",
            "level5": "H01BA02",
            "who_name": "desmopressin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01B",
            "level3_description": "POSTERIOR PITUITARY LOBE HORMONES",
            "level4": "H01BA",
            "level4_description": "Vasopressin and analogues",
            "level5": "H01BA03",
            "who_name": "lypressin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01B",
            "level3_description": "POSTERIOR PITUITARY LOBE HORMONES",
            "level4": "H01BA",
            "level4_description": "Vasopressin and analogues",
            "level5": "H01BA04",
            "who_name": "terlipressin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01B",
            "level3_description": "POSTERIOR PITUITARY LOBE HORMONES",
            "level4": "H01BA",
            "level4_description": "Vasopressin and analogues",
            "level5": "H01BA05",
            "who_name": "ornipressin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01B",
            "level3_description": "POSTERIOR PITUITARY LOBE HORMONES",
            "level4": "H01BB",
            "level4_description": "Oxytocin and analogues",
            "level5": "H01BB01",
            "who_name": "demoxytocin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01B",
            "level3_description": "POSTERIOR PITUITARY LOBE HORMONES",
            "level4": "H01BB",
            "level4_description": "Oxytocin and analogues",
            "level5": "H01BB02",
            "who_name": "oxytocin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01B",
            "level3_description": "POSTERIOR PITUITARY LOBE HORMONES",
            "level4": "H01BB",
            "level4_description": "Oxytocin and analogues",
            "level5": "H01BB03",
            "who_name": "carbetocin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01C",
            "level3_description": "HYPOTHALAMIC HORMONES",
            "level4": "H01CA",
            "level4_description": "Gonadotropin-releasing hormones",
            "level5": "H01CA01",
            "who_name": "gonadorelin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01C",
            "level3_description": "HYPOTHALAMIC HORMONES",
            "level4": "H01CA",
            "level4_description": "Gonadotropin-releasing hormones",
            "level5": "H01CA02",
            "who_name": "nafarelin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01C",
            "level3_description": "HYPOTHALAMIC HORMONES",
            "level4": "H01CB",
            "level4_description": "Somatostatin and analogues",
            "level5": "H01CB01",
            "who_name": "somatostatin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01C",
            "level3_description": "HYPOTHALAMIC HORMONES",
            "level4": "H01CB",
            "level4_description": "Somatostatin and analogues",
            "level5": "H01CB02",
            "who_name": "octreotide"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01C",
            "level3_description": "HYPOTHALAMIC HORMONES",
            "level4": "H01CB",
            "level4_description": "Somatostatin and analogues",
            "level5": "H01CB03",
            "who_name": "lanreotide"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01C",
            "level3_description": "HYPOTHALAMIC HORMONES",
            "level4": "H01CB",
            "level4_description": "Somatostatin and analogues",
            "level5": "H01CB04",
            "who_name": "vapreotide"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01C",
            "level3_description": "HYPOTHALAMIC HORMONES",
            "level4": "H01CB",
            "level4_description": "Somatostatin and analogues",
            "level5": "H01CB05",
            "who_name": "pasireotide"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01C",
            "level3_description": "HYPOTHALAMIC HORMONES",
            "level4": "H01CC",
            "level4_description": "Anti-gonadotropin-releasing hormones",
            "level5": "H01CC01",
            "who_name": "ganirelix"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01C",
            "level3_description": "HYPOTHALAMIC HORMONES",
            "level4": "H01CC",
            "level4_description": "Anti-gonadotropin-releasing hormones",
            "level5": "H01CC02",
            "who_name": "cetrorelix"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01C",
            "level3_description": "HYPOTHALAMIC HORMONES",
            "level4": "H01CC",
            "level4_description": "Anti-gonadotropin-releasing hormones",
            "level5": "H01CC03",
            "who_name": "elagolix"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01C",
            "level3_description": "HYPOTHALAMIC HORMONES",
            "level4": "H01CC",
            "level4_description": "Anti-gonadotropin-releasing hormones",
            "level5": "H01CC04",
            "who_name": "linzagolix"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H01",
            "level2_description": "PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES",
            "level3": "H01C",
            "level3_description": "HYPOTHALAMIC HORMONES",
            "level4": "H01CC",
            "level4_description": "Anti-gonadotropin-releasing hormones",
            "level5": "H01CC54",
            "who_name": "relugolix, estradiol and norethisterone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AA",
            "level4_description": "Mineralocorticoids",
            "level5": "H02AA01",
            "who_name": "aldosterone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AA",
            "level4_description": "Mineralocorticoids",
            "level5": "H02AA02",
            "who_name": "fludrocortisone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AA",
            "level4_description": "Mineralocorticoids",
            "level5": "H02AA03",
            "who_name": "desoxycortone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB01",
            "who_name": "betamethasone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB02",
            "who_name": "dexamethasone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB03",
            "who_name": "fluocortolone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB04",
            "who_name": "methylprednisolone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB05",
            "who_name": "paramethasone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB06",
            "who_name": "prednisolone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB07",
            "who_name": "prednisone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB08",
            "who_name": "triamcinolone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB09",
            "who_name": "hydrocortisone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB10",
            "who_name": "cortisone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB11",
            "who_name": "prednylidene"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB12",
            "who_name": "rimexolone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB13",
            "who_name": "deflazacort"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB14",
            "who_name": "cloprednol"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB15",
            "who_name": "meprednisone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02A",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN",
            "level4": "H02AB",
            "level4_description": "Glucocorticoids",
            "level5": "H02AB17",
            "who_name": "cortivazol"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02B",
            "level3_description": "CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS",
            "level4": "H02BX",
            "level4_description": "Corticosteroids for systemic use, combinations",
            "level5": "H02BX01",
            "who_name": "methylprednisolone, combinations"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02C",
            "level3_description": "ANTIADRENAL PREPARATIONS",
            "level4": "H02CA",
            "level4_description": "Anticorticosteroids",
            "level5": "H02CA01",
            "who_name": "trilostane"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02C",
            "level3_description": "ANTIADRENAL PREPARATIONS",
            "level4": "H02CA",
            "level4_description": "Anticorticosteroids",
            "level5": "H02CA02",
            "who_name": "osilodrostat"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H02",
            "level2_description": "CORTICOSTEROIDS FOR SYSTEMIC USE",
            "level3": "H02C",
            "level3_description": "ANTIADRENAL PREPARATIONS",
            "level4": "H02CA",
            "level4_description": "Anticorticosteroids",
            "level5": "H02CA03",
            "who_name": "ketoconazole"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03A",
            "level3_description": "THYROID PREPARATIONS",
            "level4": "H03AA",
            "level4_description": "Thyroid hormones",
            "level5": "H03AA01",
            "who_name": "levothyroxine sodium"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03A",
            "level3_description": "THYROID PREPARATIONS",
            "level4": "H03AA",
            "level4_description": "Thyroid hormones",
            "level5": "H03AA02",
            "who_name": "liothyronine sodium"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03A",
            "level3_description": "THYROID PREPARATIONS",
            "level4": "H03AA",
            "level4_description": "Thyroid hormones",
            "level5": "H03AA03",
            "who_name": "combinations of levothyroxine and liothyronine"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03A",
            "level3_description": "THYROID PREPARATIONS",
            "level4": "H03AA",
            "level4_description": "Thyroid hormones",
            "level5": "H03AA04",
            "who_name": "tiratricol"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03A",
            "level3_description": "THYROID PREPARATIONS",
            "level4": "H03AA",
            "level4_description": "Thyroid hormones",
            "level5": "H03AA05",
            "who_name": "thyroid gland preparations"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03B",
            "level3_description": "ANTITHYROID PREPARATIONS",
            "level4": "H03BA",
            "level4_description": "Thiouracils",
            "level5": "H03BA01",
            "who_name": "methylthiouracil"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03B",
            "level3_description": "ANTITHYROID PREPARATIONS",
            "level4": "H03BA",
            "level4_description": "Thiouracils",
            "level5": "H03BA02",
            "who_name": "propylthiouracil"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03B",
            "level3_description": "ANTITHYROID PREPARATIONS",
            "level4": "H03BA",
            "level4_description": "Thiouracils",
            "level5": "H03BA03",
            "who_name": "benzylthiouracil"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03B",
            "level3_description": "ANTITHYROID PREPARATIONS",
            "level4": "H03BB",
            "level4_description": "Sulfur-containing imidazole derivatives",
            "level5": "H03BB01",
            "who_name": "carbimazole"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03B",
            "level3_description": "ANTITHYROID PREPARATIONS",
            "level4": "H03BB",
            "level4_description": "Sulfur-containing imidazole derivatives",
            "level5": "H03BB02",
            "who_name": "thiamazole"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03B",
            "level3_description": "ANTITHYROID PREPARATIONS",
            "level4": "H03BB",
            "level4_description": "Sulfur-containing imidazole derivatives",
            "level5": "H03BB52",
            "who_name": "thiamazole, combinations"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03B",
            "level3_description": "ANTITHYROID PREPARATIONS",
            "level4": "H03BC",
            "level4_description": "Perchlorates",
            "level5": "H03BC01",
            "who_name": "potassium perchlorate"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03B",
            "level3_description": "ANTITHYROID PREPARATIONS",
            "level4": "H03BX",
            "level4_description": "Other antithyroid preparations",
            "level5": "H03BX01",
            "who_name": "diiodotyrosine"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H03",
            "level2_description": "THYROID THERAPY",
            "level3": "H03B",
            "level3_description": "ANTITHYROID PREPARATIONS",
            "level4": "H03BX",
            "level4_description": "Other antithyroid preparations",
            "level5": "H03BX02",
            "who_name": "dibromotyrosine"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H04",
            "level2_description": "PANCREATIC HORMONES",
            "level3": "H04A",
            "level3_description": "GLYCOGENOLYTIC HORMONES",
            "level4": "H04AA",
            "level4_description": "Glycogenolytic hormones",
            "level5": "H04AA01",
            "who_name": "glucagon"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05A",
            "level3_description": "PARATHYROID HORMONES AND ANALOGUES",
            "level4": "H05AA",
            "level4_description": "Parathyroid hormones and analogues",
            "level5": "H05AA01",
            "who_name": "parathyroid gland extract"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05A",
            "level3_description": "PARATHYROID HORMONES AND ANALOGUES",
            "level4": "H05AA",
            "level4_description": "Parathyroid hormones and analogues",
            "level5": "H05AA02",
            "who_name": "teriparatide"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05A",
            "level3_description": "PARATHYROID HORMONES AND ANALOGUES",
            "level4": "H05AA",
            "level4_description": "Parathyroid hormones and analogues",
            "level5": "H05AA03",
            "who_name": "parathyroid hormone"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05A",
            "level3_description": "PARATHYROID HORMONES AND ANALOGUES",
            "level4": "H05AA",
            "level4_description": "Parathyroid hormones and analogues",
            "level5": "H05AA04",
            "who_name": "abaloparatide"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05B",
            "level3_description": "ANTI-PARATHYROID AGENTS",
            "level4": "H05BA",
            "level4_description": "Calcitonin preparations",
            "level5": "H05BA01",
            "who_name": "calcitonin (salmon synthetic)"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05B",
            "level3_description": "ANTI-PARATHYROID AGENTS",
            "level4": "H05BA",
            "level4_description": "Calcitonin preparations",
            "level5": "H05BA02",
            "who_name": "calcitonin (pork natural)"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05B",
            "level3_description": "ANTI-PARATHYROID AGENTS",
            "level4": "H05BA",
            "level4_description": "Calcitonin preparations",
            "level5": "H05BA03",
            "who_name": "calcitonin (human synthetic)"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05B",
            "level3_description": "ANTI-PARATHYROID AGENTS",
            "level4": "H05BA",
            "level4_description": "Calcitonin preparations",
            "level5": "H05BA04",
            "who_name": "elcatonin"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05B",
            "level3_description": "ANTI-PARATHYROID AGENTS",
            "level4": "H05BX",
            "level4_description": "Other anti-parathyroid agents",
            "level5": "H05BX01",
            "who_name": "cinacalcet"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05B",
            "level3_description": "ANTI-PARATHYROID AGENTS",
            "level4": "H05BX",
            "level4_description": "Other anti-parathyroid agents",
            "level5": "H05BX02",
            "who_name": "paricalcitol"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05B",
            "level3_description": "ANTI-PARATHYROID AGENTS",
            "level4": "H05BX",
            "level4_description": "Other anti-parathyroid agents",
            "level5": "H05BX03",
            "who_name": "doxercalciferol"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05B",
            "level3_description": "ANTI-PARATHYROID AGENTS",
            "level4": "H05BX",
            "level4_description": "Other anti-parathyroid agents",
            "level5": "H05BX04",
            "who_name": "etelcalcetide"
        },
        {
            "level1": "H",
            "level1_description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS",
            "level2": "H05",
            "level2_description": "CALCIUM HOMEOSTASIS",
            "level3": "H05B",
            "level3_description": "ANTI-PARATHYROID AGENTS",
            "level4": "H05BX",
            "level4_description": "Other anti-parathyroid agents",
            "level5": "H05BX05",
            "who_name": "calcifediol"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA01",
            "who_name": "demeclocycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA02",
            "who_name": "doxycycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA03",
            "who_name": "chlortetracycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA04",
            "who_name": "lymecycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA05",
            "who_name": "metacycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA06",
            "who_name": "oxytetracycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA07",
            "who_name": "tetracycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA08",
            "who_name": "minocycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA09",
            "who_name": "rolitetracycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA10",
            "who_name": "penimepicycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA11",
            "who_name": "clomocycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA12",
            "who_name": "tigecycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA13",
            "who_name": "eravacycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA14",
            "who_name": "sarecycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA15",
            "who_name": "omadacycline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA20",
            "who_name": "combinations of tetracyclines"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01A",
            "level3_description": "TETRACYCLINES",
            "level4": "J01AA",
            "level4_description": "Tetracyclines",
            "level5": "J01AA56",
            "who_name": "oxytetracycline, combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01B",
            "level3_description": "AMPHENICOLS",
            "level4": "J01BA",
            "level4_description": "Amphenicols",
            "level5": "J01BA01",
            "who_name": "chloramphenicol"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01B",
            "level3_description": "AMPHENICOLS",
            "level4": "J01BA",
            "level4_description": "Amphenicols",
            "level5": "J01BA02",
            "who_name": "thiamphenicol"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01B",
            "level3_description": "AMPHENICOLS",
            "level4": "J01BA",
            "level4_description": "Amphenicols",
            "level5": "J01BA52",
            "who_name": "thiamphenicol, combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA01",
            "who_name": "ampicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA02",
            "who_name": "pivampicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA03",
            "who_name": "carbenicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA04",
            "who_name": "amoxicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA05",
            "who_name": "carindacillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA06",
            "who_name": "bacampicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA07",
            "who_name": "epicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA08",
            "who_name": "pivmecillinam"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA09",
            "who_name": "azlocillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA10",
            "who_name": "mezlocillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA11",
            "who_name": "mecillinam"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA12",
            "who_name": "piperacillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA13",
            "who_name": "ticarcillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA14",
            "who_name": "metampicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA15",
            "who_name": "talampicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA16",
            "who_name": "sulbenicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA17",
            "who_name": "temocillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA18",
            "who_name": "hetacillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA19",
            "who_name": "aspoxicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA20",
            "who_name": "combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CA",
            "level4_description": "Penicillins with extended spectrum",
            "level5": "J01CA51",
            "who_name": "ampicillin, combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CE",
            "level4_description": "Beta-lactamase sensitive penicillins",
            "level5": "J01CE01",
            "who_name": "benzylpenicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CE",
            "level4_description": "Beta-lactamase sensitive penicillins",
            "level5": "J01CE02",
            "who_name": "phenoxymethylpenicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CE",
            "level4_description": "Beta-lactamase sensitive penicillins",
            "level5": "J01CE03",
            "who_name": "propicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CE",
            "level4_description": "Beta-lactamase sensitive penicillins",
            "level5": "J01CE04",
            "who_name": "azidocillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CE",
            "level4_description": "Beta-lactamase sensitive penicillins",
            "level5": "J01CE05",
            "who_name": "pheneticillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CE",
            "level4_description": "Beta-lactamase sensitive penicillins",
            "level5": "J01CE06",
            "who_name": "penamecillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CE",
            "level4_description": "Beta-lactamase sensitive penicillins",
            "level5": "J01CE07",
            "who_name": "clometocillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CE",
            "level4_description": "Beta-lactamase sensitive penicillins",
            "level5": "J01CE08",
            "who_name": "benzathine benzylpenicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CE",
            "level4_description": "Beta-lactamase sensitive penicillins",
            "level5": "J01CE09",
            "who_name": "procaine benzylpenicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CE",
            "level4_description": "Beta-lactamase sensitive penicillins",
            "level5": "J01CE10",
            "who_name": "benzathine phenoxymethylpenicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CE",
            "level4_description": "Beta-lactamase sensitive penicillins",
            "level5": "J01CE30",
            "who_name": "combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CF",
            "level4_description": "Beta-lactamase resistant penicillins",
            "level5": "J01CF01",
            "who_name": "dicloxacillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CF",
            "level4_description": "Beta-lactamase resistant penicillins",
            "level5": "J01CF02",
            "who_name": "cloxacillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CF",
            "level4_description": "Beta-lactamase resistant penicillins",
            "level5": "J01CF03",
            "who_name": "meticillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CF",
            "level4_description": "Beta-lactamase resistant penicillins",
            "level5": "J01CF04",
            "who_name": "oxacillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CF",
            "level4_description": "Beta-lactamase resistant penicillins",
            "level5": "J01CF05",
            "who_name": "flucloxacillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CF",
            "level4_description": "Beta-lactamase resistant penicillins",
            "level5": "J01CF06",
            "who_name": "nafcillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CG",
            "level4_description": "Beta-lactamase inhibitors",
            "level5": "J01CG01",
            "who_name": "sulbactam"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CG",
            "level4_description": "Beta-lactamase inhibitors",
            "level5": "J01CG02",
            "who_name": "tazobactam"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CR",
            "level4_description": "Combinations of penicillins, incl. beta-lactamase inhibitors",
            "level5": "J01CR01",
            "who_name": "ampicillin and beta-lactamase inhibitor"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CR",
            "level4_description": "Combinations of penicillins, incl. beta-lactamase inhibitors",
            "level5": "J01CR02",
            "who_name": "amoxicillin and beta-lactamase inhibitor"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CR",
            "level4_description": "Combinations of penicillins, incl. beta-lactamase inhibitors",
            "level5": "J01CR03",
            "who_name": "ticarcillin and beta-lactamase inhibitor"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CR",
            "level4_description": "Combinations of penicillins, incl. beta-lactamase inhibitors",
            "level5": "J01CR04",
            "who_name": "sultamicillin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CR",
            "level4_description": "Combinations of penicillins, incl. beta-lactamase inhibitors",
            "level5": "J01CR05",
            "who_name": "piperacillin and beta-lactamase inhibitor"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01C",
            "level3_description": "BETA-LACTAM ANTIBACTERIALS, PENICILLINS",
            "level4": "J01CR",
            "level4_description": "Combinations of penicillins, incl. beta-lactamase inhibitors",
            "level5": "J01CR50",
            "who_name": "combinations of penicillins"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DB",
            "level4_description": "First-generation cephalosporins",
            "level5": "J01DB01",
            "who_name": "cefalexin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DB",
            "level4_description": "First-generation cephalosporins",
            "level5": "J01DB02",
            "who_name": "cefaloridine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DB",
            "level4_description": "First-generation cephalosporins",
            "level5": "J01DB03",
            "who_name": "cefalotin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DB",
            "level4_description": "First-generation cephalosporins",
            "level5": "J01DB04",
            "who_name": "cefazolin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DB",
            "level4_description": "First-generation cephalosporins",
            "level5": "J01DB05",
            "who_name": "cefadroxil"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DB",
            "level4_description": "First-generation cephalosporins",
            "level5": "J01DB06",
            "who_name": "cefazedone"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DB",
            "level4_description": "First-generation cephalosporins",
            "level5": "J01DB07",
            "who_name": "cefatrizine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DB",
            "level4_description": "First-generation cephalosporins",
            "level5": "J01DB08",
            "who_name": "cefapirin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DB",
            "level4_description": "First-generation cephalosporins",
            "level5": "J01DB09",
            "who_name": "cefradine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DB",
            "level4_description": "First-generation cephalosporins",
            "level5": "J01DB10",
            "who_name": "cefacetrile"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DB",
            "level4_description": "First-generation cephalosporins",
            "level5": "J01DB11",
            "who_name": "cefroxadine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DB",
            "level4_description": "First-generation cephalosporins",
            "level5": "J01DB12",
            "who_name": "ceftezole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC01",
            "who_name": "cefoxitin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC02",
            "who_name": "cefuroxime"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC03",
            "who_name": "cefamandole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC04",
            "who_name": "cefaclor"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC05",
            "who_name": "cefotetan"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC06",
            "who_name": "cefonicid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC07",
            "who_name": "cefotiam"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC08",
            "who_name": "loracarbef"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC09",
            "who_name": "cefmetazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC10",
            "who_name": "cefprozil"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC11",
            "who_name": "ceforanide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC12",
            "who_name": "cefminox"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC13",
            "who_name": "cefbuperazone"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DC",
            "level4_description": "Second-generation cephalosporins",
            "level5": "J01DC14",
            "who_name": "flomoxef"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD01",
            "who_name": "cefotaxime"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD02",
            "who_name": "ceftazidime"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD03",
            "who_name": "cefsulodin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD04",
            "who_name": "ceftriaxone"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD05",
            "who_name": "cefmenoxime"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD06",
            "who_name": "latamoxef"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD07",
            "who_name": "ceftizoxime"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD08",
            "who_name": "cefixime"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD09",
            "who_name": "cefodizime"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD10",
            "who_name": "cefetamet"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD11",
            "who_name": "cefpiramide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD12",
            "who_name": "cefoperazone"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD13",
            "who_name": "cefpodoxime"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD14",
            "who_name": "ceftibuten"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD15",
            "who_name": "cefdinir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD16",
            "who_name": "cefditoren"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD17",
            "who_name": "cefcapene"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD18",
            "who_name": "cefteram"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD51",
            "who_name": "cefotaxime and beta-lactamase inhibitor"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD52",
            "who_name": "ceftazidime and beta-lactamase inhibitor"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD54",
            "who_name": "ceftriaxone, combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD62",
            "who_name": "cefoperazone and beta-lactamase inhibitor"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD63",
            "who_name": "ceftriaxone and beta-lactamase inhibitor"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DD",
            "level4_description": "Third-generation cephalosporins",
            "level5": "J01DD64",
            "who_name": "cefpodoxime and beta-lactamase inhibitor"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DE",
            "level4_description": "Fourth-generation cephalosporins",
            "level5": "J01DE01",
            "who_name": "cefepime"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DE",
            "level4_description": "Fourth-generation cephalosporins",
            "level5": "J01DE02",
            "who_name": "cefpirome"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DE",
            "level4_description": "Fourth-generation cephalosporins",
            "level5": "J01DE03",
            "who_name": "cefozopran"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DF",
            "level4_description": "Monobactams",
            "level5": "J01DF01",
            "who_name": "aztreonam"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DF",
            "level4_description": "Monobactams",
            "level5": "J01DF02",
            "who_name": "carumonam"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DH",
            "level4_description": "Carbapenems",
            "level5": "J01DH02",
            "who_name": "meropenem"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DH",
            "level4_description": "Carbapenems",
            "level5": "J01DH03",
            "who_name": "ertapenem"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DH",
            "level4_description": "Carbapenems",
            "level5": "J01DH04",
            "who_name": "doripenem"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DH",
            "level4_description": "Carbapenems",
            "level5": "J01DH05",
            "who_name": "biapenem"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DH",
            "level4_description": "Carbapenems",
            "level5": "J01DH06",
            "who_name": "tebipenem pivoxil"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DH",
            "level4_description": "Carbapenems",
            "level5": "J01DH51",
            "who_name": "imipenem and cilastatin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DH",
            "level4_description": "Carbapenems",
            "level5": "J01DH52",
            "who_name": "meropenem and vaborbactam"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DH",
            "level4_description": "Carbapenems",
            "level5": "J01DH55",
            "who_name": "panipenem and betamipron"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DH",
            "level4_description": "Carbapenems",
            "level5": "J01DH56",
            "who_name": "imipenem, cilastatin and relebactam"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DI",
            "level4_description": "Other cephalosporins and penems",
            "level5": "J01DI01",
            "who_name": "ceftobiprole medocaril"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DI",
            "level4_description": "Other cephalosporins and penems",
            "level5": "J01DI02",
            "who_name": "ceftaroline fosamil"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DI",
            "level4_description": "Other cephalosporins and penems",
            "level5": "J01DI03",
            "who_name": "faropenem"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DI",
            "level4_description": "Other cephalosporins and penems",
            "level5": "J01DI04",
            "who_name": "cefiderocol"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01D",
            "level3_description": "OTHER BETA-LACTAM ANTIBACTERIALS",
            "level4": "J01DI",
            "level4_description": "Other cephalosporins and penems",
            "level5": "J01DI54",
            "who_name": "ceftolozane and beta-lactamase inhibitor"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EA",
            "level4_description": "Trimethoprim and derivatives",
            "level5": "J01EA01",
            "who_name": "trimethoprim"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EA",
            "level4_description": "Trimethoprim and derivatives",
            "level5": "J01EA02",
            "who_name": "brodimoprim"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EA",
            "level4_description": "Trimethoprim and derivatives",
            "level5": "J01EA03",
            "who_name": "iclaprim"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EB",
            "level4_description": "Short-acting sulfonamides",
            "level5": "J01EB01",
            "who_name": "sulfaisodimidine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EB",
            "level4_description": "Short-acting sulfonamides",
            "level5": "J01EB02",
            "who_name": "sulfamethizole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EB",
            "level4_description": "Short-acting sulfonamides",
            "level5": "J01EB03",
            "who_name": "sulfadimidine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EB",
            "level4_description": "Short-acting sulfonamides",
            "level5": "J01EB04",
            "who_name": "sulfapyridine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EB",
            "level4_description": "Short-acting sulfonamides",
            "level5": "J01EB05",
            "who_name": "sulfafurazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EB",
            "level4_description": "Short-acting sulfonamides",
            "level5": "J01EB06",
            "who_name": "sulfanilamide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EB",
            "level4_description": "Short-acting sulfonamides",
            "level5": "J01EB07",
            "who_name": "sulfathiazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EB",
            "level4_description": "Short-acting sulfonamides",
            "level5": "J01EB08",
            "who_name": "sulfathiourea"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EB",
            "level4_description": "Short-acting sulfonamides",
            "level5": "J01EB20",
            "who_name": "combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EC",
            "level4_description": "Intermediate-acting sulfonamides",
            "level5": "J01EC01",
            "who_name": "sulfamethoxazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EC",
            "level4_description": "Intermediate-acting sulfonamides",
            "level5": "J01EC02",
            "who_name": "sulfadiazine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EC",
            "level4_description": "Intermediate-acting sulfonamides",
            "level5": "J01EC03",
            "who_name": "sulfamoxole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EC",
            "level4_description": "Intermediate-acting sulfonamides",
            "level5": "J01EC20",
            "who_name": "combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01ED",
            "level4_description": "Long-acting sulfonamides",
            "level5": "J01ED01",
            "who_name": "sulfadimethoxine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01ED",
            "level4_description": "Long-acting sulfonamides",
            "level5": "J01ED02",
            "who_name": "sulfalene"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01ED",
            "level4_description": "Long-acting sulfonamides",
            "level5": "J01ED03",
            "who_name": "sulfametomidine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01ED",
            "level4_description": "Long-acting sulfonamides",
            "level5": "J01ED04",
            "who_name": "sulfametoxydiazine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01ED",
            "level4_description": "Long-acting sulfonamides",
            "level5": "J01ED05",
            "who_name": "sulfamethoxypyridazine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01ED",
            "level4_description": "Long-acting sulfonamides",
            "level5": "J01ED06",
            "who_name": "sulfaperin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01ED",
            "level4_description": "Long-acting sulfonamides",
            "level5": "J01ED07",
            "who_name": "sulfamerazine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01ED",
            "level4_description": "Long-acting sulfonamides",
            "level5": "J01ED08",
            "who_name": "sulfaphenazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01ED",
            "level4_description": "Long-acting sulfonamides",
            "level5": "J01ED09",
            "who_name": "sulfamazone"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01ED",
            "level4_description": "Long-acting sulfonamides",
            "level5": "J01ED20",
            "who_name": "combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EE",
            "level4_description": "Combinations of sulfonamides and trimethoprim, incl. derivatives",
            "level5": "J01EE01",
            "who_name": "sulfamethoxazole and trimethoprim"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EE",
            "level4_description": "Combinations of sulfonamides and trimethoprim, incl. derivatives",
            "level5": "J01EE02",
            "who_name": "sulfadiazine and trimethoprim"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EE",
            "level4_description": "Combinations of sulfonamides and trimethoprim, incl. derivatives",
            "level5": "J01EE03",
            "who_name": "sulfametrole and trimethoprim"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EE",
            "level4_description": "Combinations of sulfonamides and trimethoprim, incl. derivatives",
            "level5": "J01EE04",
            "who_name": "sulfamoxole and trimethoprim"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EE",
            "level4_description": "Combinations of sulfonamides and trimethoprim, incl. derivatives",
            "level5": "J01EE05",
            "who_name": "sulfadimidine and trimethoprim"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EE",
            "level4_description": "Combinations of sulfonamides and trimethoprim, incl. derivatives",
            "level5": "J01EE06",
            "who_name": "sulfadiazine and tetroxoprim"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01E",
            "level3_description": "SULFONAMIDES AND TRIMETHOPRIM",
            "level4": "J01EE",
            "level4_description": "Combinations of sulfonamides and trimethoprim, incl. derivatives",
            "level5": "J01EE07",
            "who_name": "sulfamerazine and trimethoprim"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA01",
            "who_name": "erythromycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA02",
            "who_name": "spiramycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA03",
            "who_name": "midecamycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA05",
            "who_name": "oleandomycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA06",
            "who_name": "roxithromycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA07",
            "who_name": "josamycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA08",
            "who_name": "troleandomycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA09",
            "who_name": "clarithromycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA10",
            "who_name": "azithromycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA11",
            "who_name": "miocamycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA12",
            "who_name": "rokitamycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA13",
            "who_name": "dirithromycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA14",
            "who_name": "flurithromycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA15",
            "who_name": "telithromycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FA",
            "level4_description": "Macrolides",
            "level5": "J01FA16",
            "who_name": "solithromycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FF",
            "level4_description": "Lincosamides",
            "level5": "J01FF01",
            "who_name": "clindamycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FF",
            "level4_description": "Lincosamides",
            "level5": "J01FF02",
            "who_name": "lincomycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FG",
            "level4_description": "Streptogramins",
            "level5": "J01FG01",
            "who_name": "pristinamycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01F",
            "level3_description": "MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS",
            "level4": "J01FG",
            "level4_description": "Streptogramins",
            "level5": "J01FG02",
            "who_name": "quinupristin/dalfopristin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GA",
            "level4_description": "Streptomycins",
            "level5": "J01GA01",
            "who_name": "streptomycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GA",
            "level4_description": "Streptomycins",
            "level5": "J01GA02",
            "who_name": "streptoduocin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB01",
            "who_name": "tobramycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB03",
            "who_name": "gentamicin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB04",
            "who_name": "kanamycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB05",
            "who_name": "neomycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB06",
            "who_name": "amikacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB07",
            "who_name": "netilmicin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB08",
            "who_name": "sisomicin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB09",
            "who_name": "dibekacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB10",
            "who_name": "ribostamycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB11",
            "who_name": "isepamicin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB12",
            "who_name": "arbekacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB13",
            "who_name": "bekanamycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01G",
            "level3_description": "AMINOGLYCOSIDE ANTIBACTERIALS",
            "level4": "J01GB",
            "level4_description": "Other aminoglycosides",
            "level5": "J01GB14",
            "who_name": "plazomicin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA01",
            "who_name": "ofloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA02",
            "who_name": "ciprofloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA03",
            "who_name": "pefloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA04",
            "who_name": "enoxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA05",
            "who_name": "temafloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA06",
            "who_name": "norfloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA07",
            "who_name": "lomefloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA08",
            "who_name": "fleroxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA09",
            "who_name": "sparfloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA10",
            "who_name": "rufloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA11",
            "who_name": "grepafloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA12",
            "who_name": "levofloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA13",
            "who_name": "trovafloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA14",
            "who_name": "moxifloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA15",
            "who_name": "gemifloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA16",
            "who_name": "gatifloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA17",
            "who_name": "prulifloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA18",
            "who_name": "pazufloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA19",
            "who_name": "garenoxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA21",
            "who_name": "sitafloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA22",
            "who_name": "tosufloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA23",
            "who_name": "delafloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA24",
            "who_name": "levonadifloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MA",
            "level4_description": "Fluoroquinolones",
            "level5": "J01MA25",
            "who_name": "lascufloxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MB",
            "level4_description": "Other quinolones",
            "level5": "J01MB01",
            "who_name": "rosoxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MB",
            "level4_description": "Other quinolones",
            "level5": "J01MB02",
            "who_name": "nalidixic acid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MB",
            "level4_description": "Other quinolones",
            "level5": "J01MB03",
            "who_name": "piromidic acid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MB",
            "level4_description": "Other quinolones",
            "level5": "J01MB04",
            "who_name": "pipemidic acid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MB",
            "level4_description": "Other quinolones",
            "level5": "J01MB05",
            "who_name": "oxolinic acid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MB",
            "level4_description": "Other quinolones",
            "level5": "J01MB06",
            "who_name": "cinoxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MB",
            "level4_description": "Other quinolones",
            "level5": "J01MB07",
            "who_name": "flumequine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01M",
            "level3_description": "QUINOLONE ANTIBACTERIALS",
            "level4": "J01MB",
            "level4_description": "Other quinolones",
            "level5": "J01MB08",
            "who_name": "nemonoxacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA01",
            "who_name": "penicillins, combinations with other antibacterials"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA02",
            "who_name": "sulfonamides, combinations with other antibacterials (excl. trimethoprim)"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA03",
            "who_name": "cefuroxime and metronidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA04",
            "who_name": "spiramycin and metronidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA05",
            "who_name": "levofloxacin and ornidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA06",
            "who_name": "cefepime and amikacin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA07",
            "who_name": "azithromycin, fluconazole and secnidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA08",
            "who_name": "tetracycline and oleandomycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA09",
            "who_name": "ofloxacin and ornidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA10",
            "who_name": "ciprofloxacin and metronidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA11",
            "who_name": "ciprofloxacin and tinidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA12",
            "who_name": "ciprofloxacin and ornidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA13",
            "who_name": "norfloxacin and tinidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA14",
            "who_name": "norfloxacin and metronidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01R",
            "level3_description": "COMBINATIONS OF ANTIBACTERIALS",
            "level4": "J01RA",
            "level4_description": "Combinations of antibacterials",
            "level5": "J01RA15",
            "who_name": "cefixime and ornidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XA",
            "level4_description": "Glycopeptide antibacterials",
            "level5": "J01XA01",
            "who_name": "vancomycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XA",
            "level4_description": "Glycopeptide antibacterials",
            "level5": "J01XA02",
            "who_name": "teicoplanin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XA",
            "level4_description": "Glycopeptide antibacterials",
            "level5": "J01XA03",
            "who_name": "telavancin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XA",
            "level4_description": "Glycopeptide antibacterials",
            "level5": "J01XA04",
            "who_name": "dalbavancin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XA",
            "level4_description": "Glycopeptide antibacterials",
            "level5": "J01XA05",
            "who_name": "oritavancin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XB",
            "level4_description": "Polymyxins",
            "level5": "J01XB01",
            "who_name": "colistin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XB",
            "level4_description": "Polymyxins",
            "level5": "J01XB02",
            "who_name": "polymyxin B"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XC",
            "level4_description": "Steroid antibacterials",
            "level5": "J01XC01",
            "who_name": "fusidic acid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XD",
            "level4_description": "Imidazole derivatives",
            "level5": "J01XD01",
            "who_name": "metronidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XD",
            "level4_description": "Imidazole derivatives",
            "level5": "J01XD02",
            "who_name": "tinidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XD",
            "level4_description": "Imidazole derivatives",
            "level5": "J01XD03",
            "who_name": "ornidazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XE",
            "level4_description": "Nitrofuran derivatives",
            "level5": "J01XE01",
            "who_name": "nitrofurantoin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XE",
            "level4_description": "Nitrofuran derivatives",
            "level5": "J01XE02",
            "who_name": "nifurtoinol"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XE",
            "level4_description": "Nitrofuran derivatives",
            "level5": "J01XE03",
            "who_name": "furazidin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XE",
            "level4_description": "Nitrofuran derivatives",
            "level5": "J01XE51",
            "who_name": "nitrofurantoin, combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XX",
            "level4_description": "Other antibacterials",
            "level5": "J01XX01",
            "who_name": "fosfomycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XX",
            "level4_description": "Other antibacterials",
            "level5": "J01XX02",
            "who_name": "xibornol"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XX",
            "level4_description": "Other antibacterials",
            "level5": "J01XX03",
            "who_name": "clofoctol"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XX",
            "level4_description": "Other antibacterials",
            "level5": "J01XX04",
            "who_name": "spectinomycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XX",
            "level4_description": "Other antibacterials",
            "level5": "J01XX05",
            "who_name": "methenamine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XX",
            "level4_description": "Other antibacterials",
            "level5": "J01XX06",
            "who_name": "mandelic acid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XX",
            "level4_description": "Other antibacterials",
            "level5": "J01XX07",
            "who_name": "nitroxoline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XX",
            "level4_description": "Other antibacterials",
            "level5": "J01XX08",
            "who_name": "linezolid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XX",
            "level4_description": "Other antibacterials",
            "level5": "J01XX09",
            "who_name": "daptomycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XX",
            "level4_description": "Other antibacterials",
            "level5": "J01XX10",
            "who_name": "bacitracin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XX",
            "level4_description": "Other antibacterials",
            "level5": "J01XX11",
            "who_name": "tedizolid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J01",
            "level2_description": "ANTIBACTERIALS FOR SYSTEMIC USE",
            "level3": "J01X",
            "level3_description": "OTHER ANTIBACTERIALS",
            "level4": "J01XX",
            "level4_description": "Other antibacterials",
            "level5": "J01XX12",
            "who_name": "lefamulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AA",
            "level4_description": "Antibiotics",
            "level5": "J02AA01",
            "who_name": "amphotericin B"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AA",
            "level4_description": "Antibiotics",
            "level5": "J02AA02",
            "who_name": "hachimycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AB",
            "level4_description": "Imidazole derivatives",
            "level5": "J02AB01",
            "who_name": "miconazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AB",
            "level4_description": "Imidazole derivatives",
            "level5": "J02AB02",
            "who_name": "ketoconazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AC",
            "level4_description": "Triazole and tetrazole derivatives",
            "level5": "J02AC01",
            "who_name": "fluconazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AC",
            "level4_description": "Triazole and tetrazole derivatives",
            "level5": "J02AC02",
            "who_name": "itraconazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AC",
            "level4_description": "Triazole and tetrazole derivatives",
            "level5": "J02AC03",
            "who_name": "voriconazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AC",
            "level4_description": "Triazole and tetrazole derivatives",
            "level5": "J02AC04",
            "who_name": "posaconazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AC",
            "level4_description": "Triazole and tetrazole derivatives",
            "level5": "J02AC05",
            "who_name": "isavuconazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AC",
            "level4_description": "Triazole and tetrazole derivatives",
            "level5": "J02AC06",
            "who_name": "oteseconazole"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AX",
            "level4_description": "Other antimycotics for systemic use",
            "level5": "J02AX01",
            "who_name": "flucytosine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AX",
            "level4_description": "Other antimycotics for systemic use",
            "level5": "J02AX04",
            "who_name": "caspofungin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AX",
            "level4_description": "Other antimycotics for systemic use",
            "level5": "J02AX05",
            "who_name": "micafungin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J02",
            "level2_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level3": "J02A",
            "level3_description": "ANTIMYCOTICS FOR SYSTEMIC USE",
            "level4": "J02AX",
            "level4_description": "Other antimycotics for systemic use",
            "level5": "J02AX06",
            "who_name": "anidulafungin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AA",
            "level4_description": "Aminosalicylic acid and derivatives",
            "level5": "J04AA01",
            "who_name": "4-aminosalicylic acid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AA",
            "level4_description": "Aminosalicylic acid and derivatives",
            "level5": "J04AA02",
            "who_name": "sodium aminosalicylate"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AA",
            "level4_description": "Aminosalicylic acid and derivatives",
            "level5": "J04AA03",
            "who_name": "calcium aminosalicylate"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AB",
            "level4_description": "Antibiotics",
            "level5": "J04AB01",
            "who_name": "cycloserine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AB",
            "level4_description": "Antibiotics",
            "level5": "J04AB02",
            "who_name": "rifampicin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AB",
            "level4_description": "Antibiotics",
            "level5": "J04AB03",
            "who_name": "rifamycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AB",
            "level4_description": "Antibiotics",
            "level5": "J04AB04",
            "who_name": "rifabutin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AB",
            "level4_description": "Antibiotics",
            "level5": "J04AB05",
            "who_name": "rifapentine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AB",
            "level4_description": "Antibiotics",
            "level5": "J04AB06",
            "who_name": "enviomycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AB",
            "level4_description": "Antibiotics",
            "level5": "J04AB30",
            "who_name": "capreomycin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AC",
            "level4_description": "Hydrazides",
            "level5": "J04AC01",
            "who_name": "isoniazid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AC",
            "level4_description": "Hydrazides",
            "level5": "J04AC51",
            "who_name": "isoniazid, combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AD",
            "level4_description": "Thiocarbamide derivatives",
            "level5": "J04AD01",
            "who_name": "protionamide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AD",
            "level4_description": "Thiocarbamide derivatives",
            "level5": "J04AD02",
            "who_name": "tiocarlide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AD",
            "level4_description": "Thiocarbamide derivatives",
            "level5": "J04AD03",
            "who_name": "ethionamide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AK",
            "level4_description": "Other drugs for treatment of tuberculosis",
            "level5": "J04AK01",
            "who_name": "pyrazinamide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AK",
            "level4_description": "Other drugs for treatment of tuberculosis",
            "level5": "J04AK02",
            "who_name": "ethambutol"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AK",
            "level4_description": "Other drugs for treatment of tuberculosis",
            "level5": "J04AK03",
            "who_name": "terizidone"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AK",
            "level4_description": "Other drugs for treatment of tuberculosis",
            "level5": "J04AK04",
            "who_name": "morinamide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AK",
            "level4_description": "Other drugs for treatment of tuberculosis",
            "level5": "J04AK05",
            "who_name": "bedaquiline"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AK",
            "level4_description": "Other drugs for treatment of tuberculosis",
            "level5": "J04AK06",
            "who_name": "delamanid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AK",
            "level4_description": "Other drugs for treatment of tuberculosis",
            "level5": "J04AK07",
            "who_name": "thioacetazone"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AK",
            "level4_description": "Other drugs for treatment of tuberculosis",
            "level5": "J04AK08",
            "who_name": "pretomanid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AM",
            "level4_description": "Combinations of drugs for treatment of tuberculosis",
            "level5": "J04AM01",
            "who_name": "streptomycin and isoniazid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AM",
            "level4_description": "Combinations of drugs for treatment of tuberculosis",
            "level5": "J04AM02",
            "who_name": "rifampicin and isoniazid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AM",
            "level4_description": "Combinations of drugs for treatment of tuberculosis",
            "level5": "J04AM03",
            "who_name": "ethambutol and isoniazid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AM",
            "level4_description": "Combinations of drugs for treatment of tuberculosis",
            "level5": "J04AM04",
            "who_name": "thioacetazone and isoniazid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AM",
            "level4_description": "Combinations of drugs for treatment of tuberculosis",
            "level5": "J04AM05",
            "who_name": "rifampicin, pyrazinamide and isoniazid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AM",
            "level4_description": "Combinations of drugs for treatment of tuberculosis",
            "level5": "J04AM06",
            "who_name": "rifampicin, pyrazinamide, ethambutol and isoniazid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AM",
            "level4_description": "Combinations of drugs for treatment of tuberculosis",
            "level5": "J04AM07",
            "who_name": "rifampicin, ethambutol and isoniazid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04A",
            "level3_description": "DRUGS FOR TREATMENT OF TUBERCULOSIS",
            "level4": "J04AM",
            "level4_description": "Combinations of drugs for treatment of tuberculosis",
            "level5": "J04AM08",
            "who_name": "isoniazid, sulfamethoxazole, trimethoprim and pyridoxine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04B",
            "level3_description": "DRUGS FOR TREATMENT OF LEPRA",
            "level4": "J04BA",
            "level4_description": "Drugs for treatment of lepra",
            "level5": "J04BA01",
            "who_name": "clofazimine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04B",
            "level3_description": "DRUGS FOR TREATMENT OF LEPRA",
            "level4": "J04BA",
            "level4_description": "Drugs for treatment of lepra",
            "level5": "J04BA02",
            "who_name": "dapsone"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J04",
            "level2_description": "ANTIMYCOBACTERIALS",
            "level3": "J04B",
            "level3_description": "DRUGS FOR TREATMENT OF LEPRA",
            "level4": "J04BA",
            "level4_description": "Drugs for treatment of lepra",
            "level5": "J04BA03",
            "who_name": "aldesulfone sodium"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AA",
            "level4_description": "Thiosemicarbazones",
            "level5": "J05AA01",
            "who_name": "metisazone"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AB",
            "level4_description": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
            "level5": "J05AB01",
            "who_name": "aciclovir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AB",
            "level4_description": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
            "level5": "J05AB02",
            "who_name": "idoxuridine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AB",
            "level4_description": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
            "level5": "J05AB03",
            "who_name": "vidarabine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AB",
            "level4_description": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
            "level5": "J05AB06",
            "who_name": "ganciclovir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AB",
            "level4_description": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
            "level5": "J05AB09",
            "who_name": "famciclovir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AB",
            "level4_description": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
            "level5": "J05AB11",
            "who_name": "valaciclovir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AB",
            "level4_description": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
            "level5": "J05AB12",
            "who_name": "cidofovir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AB",
            "level4_description": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
            "level5": "J05AB13",
            "who_name": "penciclovir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AB",
            "level4_description": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
            "level5": "J05AB14",
            "who_name": "valganciclovir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AB",
            "level4_description": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
            "level5": "J05AB15",
            "who_name": "brivudine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AB",
            "level4_description": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
            "level5": "J05AB16",
            "who_name": "remdesivir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AB",
            "level4_description": "Nucleosides and nucleotides excl. reverse transcriptase inhibitors",
            "level5": "J05AB17",
            "who_name": "brincidofovir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AC",
            "level4_description": "Cyclic amines",
            "level5": "J05AC02",
            "who_name": "rimantadine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AC",
            "level4_description": "Cyclic amines",
            "level5": "J05AC03",
            "who_name": "tromantadine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AD",
            "level4_description": "Phosphonic acid derivatives",
            "level5": "J05AD01",
            "who_name": "foscarnet"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AD",
            "level4_description": "Phosphonic acid derivatives",
            "level5": "J05AD02",
            "who_name": "fosfonet"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AE",
            "level4_description": "Protease inhibitors",
            "level5": "J05AE01",
            "who_name": "saquinavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AE",
            "level4_description": "Protease inhibitors",
            "level5": "J05AE02",
            "who_name": "indinavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AE",
            "level4_description": "Protease inhibitors",
            "level5": "J05AE03",
            "who_name": "ritonavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AE",
            "level4_description": "Protease inhibitors",
            "level5": "J05AE04",
            "who_name": "nelfinavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AE",
            "level4_description": "Protease inhibitors",
            "level5": "J05AE05",
            "who_name": "amprenavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AE",
            "level4_description": "Protease inhibitors",
            "level5": "J05AE07",
            "who_name": "fosamprenavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AE",
            "level4_description": "Protease inhibitors",
            "level5": "J05AE08",
            "who_name": "atazanavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AE",
            "level4_description": "Protease inhibitors",
            "level5": "J05AE09",
            "who_name": "tipranavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AE",
            "level4_description": "Protease inhibitors",
            "level5": "J05AE10",
            "who_name": "darunavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF01",
            "who_name": "zidovudine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF02",
            "who_name": "didanosine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF03",
            "who_name": "zalcitabine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF04",
            "who_name": "stavudine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF05",
            "who_name": "lamivudine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF06",
            "who_name": "abacavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF07",
            "who_name": "tenofovir disoproxil"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF08",
            "who_name": "adefovir dipivoxil"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF09",
            "who_name": "emtricitabine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF10",
            "who_name": "entecavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF11",
            "who_name": "telbivudine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF12",
            "who_name": "clevudine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AF",
            "level4_description": "Nucleoside and nucleotide reverse transcriptase inhibitors",
            "level5": "J05AF13",
            "who_name": "tenofovir alafenamide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AG",
            "level4_description": "Non-nucleoside reverse transcriptase inhibitors",
            "level5": "J05AG01",
            "who_name": "nevirapine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AG",
            "level4_description": "Non-nucleoside reverse transcriptase inhibitors",
            "level5": "J05AG02",
            "who_name": "delavirdine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AG",
            "level4_description": "Non-nucleoside reverse transcriptase inhibitors",
            "level5": "J05AG03",
            "who_name": "efavirenz"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AG",
            "level4_description": "Non-nucleoside reverse transcriptase inhibitors",
            "level5": "J05AG04",
            "who_name": "etravirine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AG",
            "level4_description": "Non-nucleoside reverse transcriptase inhibitors",
            "level5": "J05AG05",
            "who_name": "rilpivirine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AG",
            "level4_description": "Non-nucleoside reverse transcriptase inhibitors",
            "level5": "J05AG06",
            "who_name": "doravirine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AH",
            "level4_description": "Neuraminidase inhibitors",
            "level5": "J05AH01",
            "who_name": "zanamivir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AH",
            "level4_description": "Neuraminidase inhibitors",
            "level5": "J05AH02",
            "who_name": "oseltamivir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AH",
            "level4_description": "Neuraminidase inhibitors",
            "level5": "J05AH03",
            "who_name": "peramivir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AH",
            "level4_description": "Neuraminidase inhibitors",
            "level5": "J05AH04",
            "who_name": "laninamivir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AJ",
            "level4_description": "Integrase inhibitors",
            "level5": "J05AJ01",
            "who_name": "raltegravir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AJ",
            "level4_description": "Integrase inhibitors",
            "level5": "J05AJ02",
            "who_name": "elvitegravir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AJ",
            "level4_description": "Integrase inhibitors",
            "level5": "J05AJ03",
            "who_name": "dolutegravir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AJ",
            "level4_description": "Integrase inhibitors",
            "level5": "J05AJ04",
            "who_name": "cabotegravir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP01",
            "who_name": "ribavirin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP02",
            "who_name": "telaprevir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP03",
            "who_name": "boceprevir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP04",
            "who_name": "faldaprevir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP05",
            "who_name": "simeprevir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP06",
            "who_name": "asunaprevir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP07",
            "who_name": "daclatasvir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP08",
            "who_name": "sofosbuvir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP09",
            "who_name": "dasabuvir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP10",
            "who_name": "elbasvir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP11",
            "who_name": "grazoprevir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP12",
            "who_name": "coblopasvir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP51",
            "who_name": "sofosbuvir and ledipasvir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP52",
            "who_name": "dasabuvir, ombitasvir, paritaprevir and ritonavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP53",
            "who_name": "ombitasvir, paritaprevir and ritonavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP54",
            "who_name": "elbasvir and grazoprevir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP55",
            "who_name": "sofosbuvir and velpatasvir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP56",
            "who_name": "sofosbuvir, velpatasvir and voxilaprevir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP57",
            "who_name": "glecaprevir and pibrentasvir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AP",
            "level4_description": "Antivirals for treatment of HCV infections",
            "level5": "J05AP58",
            "who_name": "daclatasvir, asunaprevir and beclabuvir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR01",
            "who_name": "zidovudine and lamivudine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR02",
            "who_name": "lamivudine and abacavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR03",
            "who_name": "tenofovir disoproxil and emtricitabine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR04",
            "who_name": "zidovudine, lamivudine and abacavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR05",
            "who_name": "zidovudine, lamivudine and nevirapine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR06",
            "who_name": "emtricitabine, tenofovir disoproxil and efavirenz"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR07",
            "who_name": "stavudine, lamivudine and nevirapine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR08",
            "who_name": "emtricitabine, tenofovir disoproxil and rilpivirine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR09",
            "who_name": "emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR10",
            "who_name": "lopinavir and ritonavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR11",
            "who_name": "lamivudine, tenofovir disoproxil and efavirenz"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR12",
            "who_name": "lamivudine and tenofovir disoproxil"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR13",
            "who_name": "lamivudine, abacavir and dolutegravir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR14",
            "who_name": "darunavir and cobicistat"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR15",
            "who_name": "atazanavir and cobicistat"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR16",
            "who_name": "lamivudine and raltegravir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR17",
            "who_name": "emtricitabine and tenofovir alafenamide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR18",
            "who_name": "emtricitabine, tenofovir alafenamide, elvitegravir and cobicistat"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR19",
            "who_name": "emtricitabine, tenofovir alafenamide and rilpivirine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR20",
            "who_name": "emtricitabine, tenofovir alafenamide and bictegravir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR21",
            "who_name": "dolutegravir and rilpivirine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR22",
            "who_name": "emtricitabine, tenofovir alafenamide, darunavir and cobicistat"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR23",
            "who_name": "atazanavir and ritonavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR24",
            "who_name": "lamivudine, tenofovir disoproxil and doravirine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR25",
            "who_name": "lamivudine and dolutegravir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR26",
            "who_name": "darunavir and ritonavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AR",
            "level4_description": "Antivirals for treatment of HIV infections, combinations",
            "level5": "J05AR27",
            "who_name": "lamivudine, tenofovir disoproxil and dolutegravir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX01",
            "who_name": "moroxydine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX02",
            "who_name": "lysozyme"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX05",
            "who_name": "inosine pranobex"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX06",
            "who_name": "pleconaril"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX07",
            "who_name": "enfuvirtide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX09",
            "who_name": "maraviroc"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX10",
            "who_name": "maribavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX13",
            "who_name": "umifenovir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX17",
            "who_name": "enisamium iodide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX18",
            "who_name": "letermovir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX19",
            "who_name": "tilorone"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX21",
            "who_name": "pentanedioic acid imidazolyl ethanamide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX23",
            "who_name": "ibalizumab"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX24",
            "who_name": "tecovirimat"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX25",
            "who_name": "baloxavir marboxil"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX26",
            "who_name": "amenamevir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX27",
            "who_name": "favipiravir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX28",
            "who_name": "bulevirtide"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX29",
            "who_name": "fostemsavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J05",
            "level2_description": "ANTIVIRALS FOR SYSTEMIC USE",
            "level3": "J05A",
            "level3_description": "DIRECT ACTING ANTIVIRALS",
            "level4": "J05AX",
            "level4_description": "Other antivirals",
            "level5": "J05AX31",
            "who_name": "lenacapavir"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06A",
            "level3_description": "IMMUNE SERA",
            "level4": "J06AA",
            "level4_description": "Immune sera",
            "level5": "J06AA01",
            "who_name": "diphtheria antitoxin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06A",
            "level3_description": "IMMUNE SERA",
            "level4": "J06AA",
            "level4_description": "Immune sera",
            "level5": "J06AA02",
            "who_name": "tetanus antitoxin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06A",
            "level3_description": "IMMUNE SERA",
            "level4": "J06AA",
            "level4_description": "Immune sera",
            "level5": "J06AA03",
            "who_name": "snake venom antiserum"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06A",
            "level3_description": "IMMUNE SERA",
            "level4": "J06AA",
            "level4_description": "Immune sera",
            "level5": "J06AA04",
            "who_name": "botulinum antitoxin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06A",
            "level3_description": "IMMUNE SERA",
            "level4": "J06AA",
            "level4_description": "Immune sera",
            "level5": "J06AA05",
            "who_name": "gas-gangrene sera"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06A",
            "level3_description": "IMMUNE SERA",
            "level4": "J06AA",
            "level4_description": "Immune sera",
            "level5": "J06AA06",
            "who_name": "rabies serum"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BA",
            "level4_description": "Immunoglobulins, normal human",
            "level5": "J06BA01",
            "who_name": "immunoglobulins, normal human, for extravascular adm."
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BA",
            "level4_description": "Immunoglobulins, normal human",
            "level5": "J06BA02",
            "who_name": "immunoglobulins, normal human, for intravascular adm."
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB01",
            "who_name": "anti-D (rh) immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB02",
            "who_name": "tetanus immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB03",
            "who_name": "varicella/zoster immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB04",
            "who_name": "hepatitis B immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB05",
            "who_name": "rabies immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB06",
            "who_name": "rubella immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB07",
            "who_name": "vaccinia immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB08",
            "who_name": "staphylococcus immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB09",
            "who_name": "cytomegalovirus immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB10",
            "who_name": "diphtheria immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB11",
            "who_name": "hepatitis A immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB12",
            "who_name": "encephalitis, tick borne immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB13",
            "who_name": "pertussis immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB14",
            "who_name": "measles immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB15",
            "who_name": "mumps immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB19",
            "who_name": "anthrax immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BB",
            "level4_description": "Specific immunoglobulins",
            "level5": "J06BB30",
            "who_name": "combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BC",
            "level4_description": "Antibacterial monoclonal antibodies",
            "level5": "J06BC01",
            "who_name": "nebacumab"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BC",
            "level4_description": "Antibacterial monoclonal antibodies",
            "level5": "J06BC02",
            "who_name": "raxibacumab"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BC",
            "level4_description": "Antibacterial monoclonal antibodies",
            "level5": "J06BC03",
            "who_name": "bezlotoxumab"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BC",
            "level4_description": "Antibacterial monoclonal antibodies",
            "level5": "J06BC04",
            "who_name": "obiltoxaximab"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BD",
            "level4_description": "Antiviral monoclonal antibodies",
            "level5": "J06BD01",
            "who_name": "palivizumab"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BD",
            "level4_description": "Antiviral monoclonal antibodies",
            "level5": "J06BD02",
            "who_name": "motavizumab"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J06",
            "level2_description": "IMMUNE SERA AND IMMUNOGLOBULINS",
            "level3": "J06B",
            "level3_description": "IMMUNOGLOBULINS",
            "level4": "J06BD",
            "level4_description": "Antiviral monoclonal antibodies",
            "level5": "J06BD03",
            "who_name": "tixagevimab and cilgavimab"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AC",
            "level4_description": "Anthrax vaccines",
            "level5": "J07AC01",
            "who_name": "anthrax antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AD",
            "level4_description": "Brucellosis vaccines",
            "level5": "J07AD01",
            "who_name": "brucella antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AE",
            "level4_description": "Cholera vaccines",
            "level5": "J07AE01",
            "who_name": "cholera, inactivated, whole cell"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AE",
            "level4_description": "Cholera vaccines",
            "level5": "J07AE02",
            "who_name": "cholera, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AE",
            "level4_description": "Cholera vaccines",
            "level5": "J07AE51",
            "who_name": "cholera, combinations with typhoid vaccine, inactivated, whole cell"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AF",
            "level4_description": "Diphtheria vaccines",
            "level5": "J07AF01",
            "who_name": "diphtheria toxoid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AG",
            "level4_description": "Haemophilus influenzae B vaccines",
            "level5": "J07AG01",
            "who_name": "hemophilus influenzae B, purified antigen conjugated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AG",
            "level4_description": "Haemophilus influenzae B vaccines",
            "level5": "J07AG51",
            "who_name": "hemophilus influenzae B, combinations with toxoids"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AG",
            "level4_description": "Haemophilus influenzae B vaccines",
            "level5": "J07AG52",
            "who_name": "hemophilus influenzae B, combinations with pertussis and toxoids"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AG",
            "level4_description": "Haemophilus influenzae B vaccines",
            "level5": "J07AG53",
            "who_name": "hemophilus influenzae B, combinations with meningococcus C, conjugated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AG",
            "level4_description": "Haemophilus influenzae B vaccines",
            "level5": "J07AG54",
            "who_name": "haemophilus influenza B, combinations with meningococcus C,Y, conjugated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AH",
            "level4_description": "Meningococcal vaccines",
            "level5": "J07AH01",
            "who_name": "meningococcus A, purified polysaccharides antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AH",
            "level4_description": "Meningococcal vaccines",
            "level5": "J07AH02",
            "who_name": "other meningococcal monovalent purified polysaccharides antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AH",
            "level4_description": "Meningococcal vaccines",
            "level5": "J07AH03",
            "who_name": "meningococcus A,C, bivalent purified polysaccharides antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AH",
            "level4_description": "Meningococcal vaccines",
            "level5": "J07AH04",
            "who_name": "meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AH",
            "level4_description": "Meningococcal vaccines",
            "level5": "J07AH05",
            "who_name": "other meningococcal polyvalent purified polysaccharides antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AH",
            "level4_description": "Meningococcal vaccines",
            "level5": "J07AH06",
            "who_name": "meningococcus B, outer membrane vesicle vaccine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AH",
            "level4_description": "Meningococcal vaccines",
            "level5": "J07AH07",
            "who_name": "meningococcus C, purified polysaccharides antigen conjugated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AH",
            "level4_description": "Meningococcal vaccines",
            "level5": "J07AH08",
            "who_name": "meningococcus A,C,Y,W-135, tetravalent purified polysaccharides antigen conjugated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AH",
            "level4_description": "Meningococcal vaccines",
            "level5": "J07AH09",
            "who_name": "meningococcus B, multicomponent vaccine"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AH",
            "level4_description": "Meningococcal vaccines",
            "level5": "J07AH10",
            "who_name": "meningococcus A, purified polysaccharides antigen conjugated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AJ",
            "level4_description": "Pertussis vaccines",
            "level5": "J07AJ01",
            "who_name": "pertussis, inactivated, whole cell"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AJ",
            "level4_description": "Pertussis vaccines",
            "level5": "J07AJ02",
            "who_name": "pertussis, purified antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AJ",
            "level4_description": "Pertussis vaccines",
            "level5": "J07AJ51",
            "who_name": "pertussis, inactivated, whole cell, combinations with toxoids"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AJ",
            "level4_description": "Pertussis vaccines",
            "level5": "J07AJ52",
            "who_name": "pertussis, purified antigen, combinations with toxoids"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AK",
            "level4_description": "Plague vaccines",
            "level5": "J07AK01",
            "who_name": "plague, inactivated, whole cell"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AL",
            "level4_description": "Pneumococcal vaccines",
            "level5": "J07AL01",
            "who_name": "pneumococcus, purified polysaccharides antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AL",
            "level4_description": "Pneumococcal vaccines",
            "level5": "J07AL02",
            "who_name": "pneumococcus, purified polysaccharides antigen conjugated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AL",
            "level4_description": "Pneumococcal vaccines",
            "level5": "J07AL52",
            "who_name": "pneumococcus purified polysaccharides antigen and haemophilus influenzae, conjugated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AM",
            "level4_description": "Tetanus vaccines",
            "level5": "J07AM01",
            "who_name": "tetanus toxoid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AM",
            "level4_description": "Tetanus vaccines",
            "level5": "J07AM51",
            "who_name": "tetanus toxoid, combinations with diphtheria toxoid"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AM",
            "level4_description": "Tetanus vaccines",
            "level5": "J07AM52",
            "who_name": "tetanus toxoid, combinations with tetanus immunoglobulin"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AN",
            "level4_description": "Tuberculosis vaccines",
            "level5": "J07AN01",
            "who_name": "tuberculosis, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AP",
            "level4_description": "Typhoid vaccines",
            "level5": "J07AP01",
            "who_name": "typhoid, oral, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AP",
            "level4_description": "Typhoid vaccines",
            "level5": "J07AP02",
            "who_name": "typhoid, inactivated, whole cell"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AP",
            "level4_description": "Typhoid vaccines",
            "level5": "J07AP03",
            "who_name": "typhoid, purified polysaccharide antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AP",
            "level4_description": "Typhoid vaccines",
            "level5": "J07AP10",
            "who_name": "typhoid, combinations with paratyphi types"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07A",
            "level3_description": "BACTERIAL VACCINES",
            "level4": "J07AR",
            "level4_description": "Typhus (exanthematicus) vaccines",
            "level5": "J07AR01",
            "who_name": "typhus exanthematicus, inactivated, whole cell"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BA",
            "level4_description": "Encephalitis vaccines",
            "level5": "J07BA01",
            "who_name": "encephalitis, tick borne, inactivated, whole virus"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BA",
            "level4_description": "Encephalitis vaccines",
            "level5": "J07BA02",
            "who_name": "encephalitis, Japanese, inactivated, whole virus"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BA",
            "level4_description": "Encephalitis vaccines",
            "level5": "J07BA03",
            "who_name": "encephalitis, Japanese, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BB",
            "level4_description": "Influenza vaccines",
            "level5": "J07BB01",
            "who_name": "influenza, inactivated, whole virus"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BB",
            "level4_description": "Influenza vaccines",
            "level5": "J07BB02",
            "who_name": "influenza, inactivated, split virus or surface antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BB",
            "level4_description": "Influenza vaccines",
            "level5": "J07BB03",
            "who_name": "influenza, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BB",
            "level4_description": "Influenza vaccines",
            "level5": "J07BB04",
            "who_name": "influenza, virus like particles"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BC",
            "level4_description": "Hepatitis vaccines",
            "level5": "J07BC01",
            "who_name": "hepatitis B, purified antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BC",
            "level4_description": "Hepatitis vaccines",
            "level5": "J07BC02",
            "who_name": "hepatitis A, inactivated, whole virus"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BC",
            "level4_description": "Hepatitis vaccines",
            "level5": "J07BC20",
            "who_name": "combinations"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BD",
            "level4_description": "Measles vaccines",
            "level5": "J07BD01",
            "who_name": "measles, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BD",
            "level4_description": "Measles vaccines",
            "level5": "J07BD51",
            "who_name": "measles, combinations with mumps, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BD",
            "level4_description": "Measles vaccines",
            "level5": "J07BD52",
            "who_name": "measles, combinations with mumps and rubella, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BD",
            "level4_description": "Measles vaccines",
            "level5": "J07BD53",
            "who_name": "measles, combinations with rubella, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BD",
            "level4_description": "Measles vaccines",
            "level5": "J07BD54",
            "who_name": "measles, combinations with mumps, rubella and varicella, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BE",
            "level4_description": "Mumps vaccines",
            "level5": "J07BE01",
            "who_name": "mumps, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BF",
            "level4_description": "Poliomyelitis vaccines",
            "level5": "J07BF01",
            "who_name": "poliomyelitis oral, monovalent, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BF",
            "level4_description": "Poliomyelitis vaccines",
            "level5": "J07BF02",
            "who_name": "poliomyelitis oral, trivalent, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BF",
            "level4_description": "Poliomyelitis vaccines",
            "level5": "J07BF03",
            "who_name": "poliomyelitis, trivalent, inactivated, whole virus"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BF",
            "level4_description": "Poliomyelitis vaccines",
            "level5": "J07BF04",
            "who_name": "poliomyelitis oral, bivalent, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BG",
            "level4_description": "Rabies vaccines",
            "level5": "J07BG01",
            "who_name": "rabies, inactivated, whole virus"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BH",
            "level4_description": "Rota virus diarrhea vaccines",
            "level5": "J07BH01",
            "who_name": "rota virus, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BH",
            "level4_description": "Rota virus diarrhea vaccines",
            "level5": "J07BH02",
            "who_name": "rota virus, pentavalent, live, reassorted"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BJ",
            "level4_description": "Rubella vaccines",
            "level5": "J07BJ01",
            "who_name": "rubella, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BJ",
            "level4_description": "Rubella vaccines",
            "level5": "J07BJ51",
            "who_name": "rubella, combinations with mumps, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BK",
            "level4_description": "Varicella zoster vaccines",
            "level5": "J07BK01",
            "who_name": "varicella, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BK",
            "level4_description": "Varicella zoster vaccines",
            "level5": "J07BK02",
            "who_name": "zoster, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BK",
            "level4_description": "Varicella zoster vaccines",
            "level5": "J07BK03",
            "who_name": "zoster, purified antigen"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BL",
            "level4_description": "Yellow fever vaccines",
            "level5": "J07BL01",
            "who_name": "yellow fever, live attenuated"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BM",
            "level4_description": "Papillomavirus vaccines",
            "level5": "J07BM01",
            "who_name": "papillomavirus (human types 6, 11, 16, 18)"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BM",
            "level4_description": "Papillomavirus vaccines",
            "level5": "J07BM02",
            "who_name": "papillomavirus (human types 16, 18)"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BM",
            "level4_description": "Papillomavirus vaccines",
            "level5": "J07BM03",
            "who_name": "papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52, 58)"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BX",
            "level4_description": "Other viral vaccines",
            "level5": "J07BX01",
            "who_name": "smallpox vaccines"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BX",
            "level4_description": "Other viral vaccines",
            "level5": "J07BX02",
            "who_name": "ebola vaccines"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BX",
            "level4_description": "Other viral vaccines",
            "level5": "J07BX03",
            "who_name": "covid-19 vaccines"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07B",
            "level3_description": "VIRAL VACCINES",
            "level4": "J07BX",
            "level4_description": "Other viral vaccines",
            "level5": "J07BX04",
            "who_name": "dengue virus vaccines"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA01",
            "who_name": "diphtheria-poliomyelitis-tetanus"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA02",
            "who_name": "diphtheria-pertussis-poliomyelitis-tetanus"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA03",
            "who_name": "diphtheria-rubella-tetanus"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA04",
            "who_name": "hemophilus influenzae B and poliomyelitis"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA05",
            "who_name": "diphtheria-hepatitis B-pertussis-tetanus"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA06",
            "who_name": "diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA07",
            "who_name": "diphtheria-hepatitis B-tetanus"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA08",
            "who_name": "hemophilus influenzae B and hepatitis B"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA09",
            "who_name": "diphtheria-hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA10",
            "who_name": "typhoid-hepatitis A"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA11",
            "who_name": "diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA12",
            "who_name": "diphtheria-pertussis-poliomyelitis-tetanus-hepatitis B"
        },
        {
            "level1": "J",
            "level1_description": "ANTIINFECTIVES FOR SYSTEMIC USE",
            "level2": "J07",
            "level2_description": "VACCINES",
            "level3": "J07C",
            "level3_description": "BACTERIAL AND VIRAL VACCINES, COMBINED",
            "level4": "J07CA",
            "level4_description": "Bacterial and viral vaccines, combined",
            "level5": "J07CA13",
            "who_name": "diphtheria-hemophilus influenzae B-pertussis-tetanus-hepatitis B-meningococcus A + C"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AA",
            "level4_description": "Nitrogen mustard analogues",
            "level5": "L01AA01",
            "who_name": "cyclophosphamide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AA",
            "level4_description": "Nitrogen mustard analogues",
            "level5": "L01AA02",
            "who_name": "chlorambucil"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AA",
            "level4_description": "Nitrogen mustard analogues",
            "level5": "L01AA03",
            "who_name": "melphalan"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AA",
            "level4_description": "Nitrogen mustard analogues",
            "level5": "L01AA05",
            "who_name": "chlormethine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AA",
            "level4_description": "Nitrogen mustard analogues",
            "level5": "L01AA06",
            "who_name": "ifosfamide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AA",
            "level4_description": "Nitrogen mustard analogues",
            "level5": "L01AA07",
            "who_name": "trofosfamide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AA",
            "level4_description": "Nitrogen mustard analogues",
            "level5": "L01AA08",
            "who_name": "prednimustine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AA",
            "level4_description": "Nitrogen mustard analogues",
            "level5": "L01AA09",
            "who_name": "bendamustine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AA",
            "level4_description": "Nitrogen mustard analogues",
            "level5": "L01AA10",
            "who_name": "melphalan flufenamide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AB",
            "level4_description": "Alkyl sulfonates",
            "level5": "L01AB01",
            "who_name": "busulfan"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AB",
            "level4_description": "Alkyl sulfonates",
            "level5": "L01AB02",
            "who_name": "treosulfan"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AB",
            "level4_description": "Alkyl sulfonates",
            "level5": "L01AB03",
            "who_name": "mannosulfan"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AC",
            "level4_description": "Ethylene imines",
            "level5": "L01AC01",
            "who_name": "thiotepa"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AC",
            "level4_description": "Ethylene imines",
            "level5": "L01AC02",
            "who_name": "triaziquone"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AC",
            "level4_description": "Ethylene imines",
            "level5": "L01AC03",
            "who_name": "carboquone"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AD",
            "level4_description": "Nitrosoureas",
            "level5": "L01AD01",
            "who_name": "carmustine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AD",
            "level4_description": "Nitrosoureas",
            "level5": "L01AD02",
            "who_name": "lomustine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AD",
            "level4_description": "Nitrosoureas",
            "level5": "L01AD03",
            "who_name": "semustine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AD",
            "level4_description": "Nitrosoureas",
            "level5": "L01AD04",
            "who_name": "streptozocin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AD",
            "level4_description": "Nitrosoureas",
            "level5": "L01AD05",
            "who_name": "fotemustine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AD",
            "level4_description": "Nitrosoureas",
            "level5": "L01AD06",
            "who_name": "nimustine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AD",
            "level4_description": "Nitrosoureas",
            "level5": "L01AD07",
            "who_name": "ranimustine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AD",
            "level4_description": "Nitrosoureas",
            "level5": "L01AD08",
            "who_name": "uramustine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AG",
            "level4_description": "Epoxides",
            "level5": "L01AG01",
            "who_name": "etoglucid"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AX",
            "level4_description": "Other alkylating agents",
            "level5": "L01AX01",
            "who_name": "mitobronitol"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AX",
            "level4_description": "Other alkylating agents",
            "level5": "L01AX02",
            "who_name": "pipobroman"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AX",
            "level4_description": "Other alkylating agents",
            "level5": "L01AX03",
            "who_name": "temozolomide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01A",
            "level3_description": "ALKYLATING AGENTS",
            "level4": "L01AX",
            "level4_description": "Other alkylating agents",
            "level5": "L01AX04",
            "who_name": "dacarbazine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BA",
            "level4_description": "Folic acid analogues",
            "level5": "L01BA01",
            "who_name": "methotrexate"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BA",
            "level4_description": "Folic acid analogues",
            "level5": "L01BA03",
            "who_name": "raltitrexed"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BA",
            "level4_description": "Folic acid analogues",
            "level5": "L01BA04",
            "who_name": "pemetrexed"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BA",
            "level4_description": "Folic acid analogues",
            "level5": "L01BA05",
            "who_name": "pralatrexate"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BB",
            "level4_description": "Purine analogues",
            "level5": "L01BB02",
            "who_name": "mercaptopurine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BB",
            "level4_description": "Purine analogues",
            "level5": "L01BB03",
            "who_name": "tioguanine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BB",
            "level4_description": "Purine analogues",
            "level5": "L01BB04",
            "who_name": "cladribine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BB",
            "level4_description": "Purine analogues",
            "level5": "L01BB05",
            "who_name": "fludarabine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BB",
            "level4_description": "Purine analogues",
            "level5": "L01BB06",
            "who_name": "clofarabine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BB",
            "level4_description": "Purine analogues",
            "level5": "L01BB07",
            "who_name": "nelarabine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BC",
            "level4_description": "Pyrimidine analogues",
            "level5": "L01BC01",
            "who_name": "cytarabine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BC",
            "level4_description": "Pyrimidine analogues",
            "level5": "L01BC02",
            "who_name": "fluorouracil"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BC",
            "level4_description": "Pyrimidine analogues",
            "level5": "L01BC03",
            "who_name": "tegafur"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BC",
            "level4_description": "Pyrimidine analogues",
            "level5": "L01BC04",
            "who_name": "carmofur"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BC",
            "level4_description": "Pyrimidine analogues",
            "level5": "L01BC05",
            "who_name": "gemcitabine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BC",
            "level4_description": "Pyrimidine analogues",
            "level5": "L01BC06",
            "who_name": "capecitabine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BC",
            "level4_description": "Pyrimidine analogues",
            "level5": "L01BC07",
            "who_name": "azacitidine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BC",
            "level4_description": "Pyrimidine analogues",
            "level5": "L01BC08",
            "who_name": "decitabine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BC",
            "level4_description": "Pyrimidine analogues",
            "level5": "L01BC09",
            "who_name": "floxuridine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BC",
            "level4_description": "Pyrimidine analogues",
            "level5": "L01BC52",
            "who_name": "fluorouracil, combinations"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BC",
            "level4_description": "Pyrimidine analogues",
            "level5": "L01BC53",
            "who_name": "tegafur, combinations"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01B",
            "level3_description": "ANTIMETABOLITES",
            "level4": "L01BC",
            "level4_description": "Pyrimidine analogues",
            "level5": "L01BC59",
            "who_name": "trifluridine, combinations"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CA",
            "level4_description": "Vinca alkaloids and analogues",
            "level5": "L01CA01",
            "who_name": "vinblastine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CA",
            "level4_description": "Vinca alkaloids and analogues",
            "level5": "L01CA02",
            "who_name": "vincristine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CA",
            "level4_description": "Vinca alkaloids and analogues",
            "level5": "L01CA03",
            "who_name": "vindesine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CA",
            "level4_description": "Vinca alkaloids and analogues",
            "level5": "L01CA04",
            "who_name": "vinorelbine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CA",
            "level4_description": "Vinca alkaloids and analogues",
            "level5": "L01CA05",
            "who_name": "vinflunine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CA",
            "level4_description": "Vinca alkaloids and analogues",
            "level5": "L01CA06",
            "who_name": "vintafolide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CB",
            "level4_description": "Podophyllotoxin derivatives",
            "level5": "L01CB01",
            "who_name": "etoposide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CB",
            "level4_description": "Podophyllotoxin derivatives",
            "level5": "L01CB02",
            "who_name": "teniposide"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CC",
            "level4_description": "Colchicine derivatives",
            "level5": "L01CC01",
            "who_name": "demecolcine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CD",
            "level4_description": "Taxanes",
            "level5": "L01CD01",
            "who_name": "paclitaxel"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CD",
            "level4_description": "Taxanes",
            "level5": "L01CD02",
            "who_name": "docetaxel"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CD",
            "level4_description": "Taxanes",
            "level5": "L01CD03",
            "who_name": "paclitaxel poliglumex"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CD",
            "level4_description": "Taxanes",
            "level5": "L01CD04",
            "who_name": "cabazitaxel"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CE",
            "level4_description": "Topoisomerase 1 (TOP1) inhibitors",
            "level5": "L01CE01",
            "who_name": "topotecan"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CE",
            "level4_description": "Topoisomerase 1 (TOP1) inhibitors",
            "level5": "L01CE02",
            "who_name": "irinotecan"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CE",
            "level4_description": "Topoisomerase 1 (TOP1) inhibitors",
            "level5": "L01CE03",
            "who_name": "etirinotecan pegol"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CE",
            "level4_description": "Topoisomerase 1 (TOP1) inhibitors",
            "level5": "L01CE04",
            "who_name": "belotecan"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01C",
            "level3_description": "PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS",
            "level4": "L01CX",
            "level4_description": "Other plant alkaloids and natural products",
            "level5": "L01CX01",
            "who_name": "trabectedin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DA",
            "level4_description": "Actinomycines",
            "level5": "L01DA01",
            "who_name": "dactinomycin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DB",
            "level4_description": "Anthracyclines and related substances",
            "level5": "L01DB01",
            "who_name": "doxorubicin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DB",
            "level4_description": "Anthracyclines and related substances",
            "level5": "L01DB02",
            "who_name": "daunorubicin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DB",
            "level4_description": "Anthracyclines and related substances",
            "level5": "L01DB03",
            "who_name": "epirubicin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DB",
            "level4_description": "Anthracyclines and related substances",
            "level5": "L01DB04",
            "who_name": "aclarubicin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DB",
            "level4_description": "Anthracyclines and related substances",
            "level5": "L01DB05",
            "who_name": "zorubicin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DB",
            "level4_description": "Anthracyclines and related substances",
            "level5": "L01DB06",
            "who_name": "idarubicin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DB",
            "level4_description": "Anthracyclines and related substances",
            "level5": "L01DB07",
            "who_name": "mitoxantrone"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DB",
            "level4_description": "Anthracyclines and related substances",
            "level5": "L01DB08",
            "who_name": "pirarubicin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DB",
            "level4_description": "Anthracyclines and related substances",
            "level5": "L01DB09",
            "who_name": "valrubicin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DB",
            "level4_description": "Anthracyclines and related substances",
            "level5": "L01DB10",
            "who_name": "amrubicin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DB",
            "level4_description": "Anthracyclines and related substances",
            "level5": "L01DB11",
            "who_name": "pixantrone"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DC",
            "level4_description": "Other cytotoxic antibiotics",
            "level5": "L01DC01",
            "who_name": "bleomycin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DC",
            "level4_description": "Other cytotoxic antibiotics",
            "level5": "L01DC02",
            "who_name": "plicamycin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DC",
            "level4_description": "Other cytotoxic antibiotics",
            "level5": "L01DC03",
            "who_name": "mitomycin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01D",
            "level3_description": "CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES",
            "level4": "L01DC",
            "level4_description": "Other cytotoxic antibiotics",
            "level5": "L01DC04",
            "who_name": "ixabepilone"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EA",
            "level4_description": "BCR-ABL tyrosine kinase inhibitors",
            "level5": "L01EA01",
            "who_name": "imatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EA",
            "level4_description": "BCR-ABL tyrosine kinase inhibitors",
            "level5": "L01EA02",
            "who_name": "dasatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EA",
            "level4_description": "BCR-ABL tyrosine kinase inhibitors",
            "level5": "L01EA03",
            "who_name": "nilotinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EA",
            "level4_description": "BCR-ABL tyrosine kinase inhibitors",
            "level5": "L01EA04",
            "who_name": "bosutinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EA",
            "level4_description": "BCR-ABL tyrosine kinase inhibitors",
            "level5": "L01EA05",
            "who_name": "ponatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EA",
            "level4_description": "BCR-ABL tyrosine kinase inhibitors",
            "level5": "L01EA06",
            "who_name": "asciminib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EB",
            "level4_description": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
            "level5": "L01EB01",
            "who_name": "gefitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EB",
            "level4_description": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
            "level5": "L01EB02",
            "who_name": "erlotinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EB",
            "level4_description": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
            "level5": "L01EB03",
            "who_name": "afatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EB",
            "level4_description": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
            "level5": "L01EB04",
            "who_name": "osimertinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EB",
            "level4_description": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
            "level5": "L01EB05",
            "who_name": "rociletinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EB",
            "level4_description": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
            "level5": "L01EB06",
            "who_name": "olmutinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EB",
            "level4_description": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
            "level5": "L01EB07",
            "who_name": "dacomitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EB",
            "level4_description": "Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors",
            "level5": "L01EB08",
            "who_name": "icotinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EC",
            "level4_description": "B-Raf serine-threonine kinase (BRAF) inhibitors",
            "level5": "L01EC01",
            "who_name": "vemurafenib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EC",
            "level4_description": "B-Raf serine-threonine kinase (BRAF) inhibitors",
            "level5": "L01EC02",
            "who_name": "dabrafenib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EC",
            "level4_description": "B-Raf serine-threonine kinase (BRAF) inhibitors",
            "level5": "L01EC03",
            "who_name": "encorafenib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01ED",
            "level4_description": "Anaplastic lymphoma kinase (ALK) inhibitors",
            "level5": "L01ED01",
            "who_name": "crizotinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01ED",
            "level4_description": "Anaplastic lymphoma kinase (ALK) inhibitors",
            "level5": "L01ED02",
            "who_name": "ceritinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01ED",
            "level4_description": "Anaplastic lymphoma kinase (ALK) inhibitors",
            "level5": "L01ED03",
            "who_name": "alectinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01ED",
            "level4_description": "Anaplastic lymphoma kinase (ALK) inhibitors",
            "level5": "L01ED04",
            "who_name": "brigatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01ED",
            "level4_description": "Anaplastic lymphoma kinase (ALK) inhibitors",
            "level5": "L01ED05",
            "who_name": "lorlatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EE",
            "level4_description": "Mitogen-activated protein kinase (MEK) inhibitors",
            "level5": "L01EE01",
            "who_name": "trametinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EE",
            "level4_description": "Mitogen-activated protein kinase (MEK) inhibitors",
            "level5": "L01EE02",
            "who_name": "cobimetinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EE",
            "level4_description": "Mitogen-activated protein kinase (MEK) inhibitors",
            "level5": "L01EE03",
            "who_name": "binimetinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EE",
            "level4_description": "Mitogen-activated protein kinase (MEK) inhibitors",
            "level5": "L01EE04",
            "who_name": "selumetinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EF",
            "level4_description": "Cyclin-dependent kinase (CDK) inhibitors",
            "level5": "L01EF01",
            "who_name": "palbociclib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EF",
            "level4_description": "Cyclin-dependent kinase (CDK) inhibitors",
            "level5": "L01EF02",
            "who_name": "ribociclib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EF",
            "level4_description": "Cyclin-dependent kinase (CDK) inhibitors",
            "level5": "L01EF03",
            "who_name": "abemaciclib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EG",
            "level4_description": "Mammalian target of rapamycin (mTOR) kinase inhibitors",
            "level5": "L01EG01",
            "who_name": "temsirolimus"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EG",
            "level4_description": "Mammalian target of rapamycin (mTOR) kinase inhibitors",
            "level5": "L01EG02",
            "who_name": "everolimus"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EG",
            "level4_description": "Mammalian target of rapamycin (mTOR) kinase inhibitors",
            "level5": "L01EG03",
            "who_name": "ridaforolimus"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EH",
            "level4_description": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors",
            "level5": "L01EH01",
            "who_name": "lapatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EH",
            "level4_description": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors",
            "level5": "L01EH02",
            "who_name": "neratinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EH",
            "level4_description": "Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors",
            "level5": "L01EH03",
            "who_name": "tucatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EJ",
            "level4_description": "Janus-associated kinase (JAK) inhibitors",
            "level5": "L01EJ01",
            "who_name": "ruxolitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EJ",
            "level4_description": "Janus-associated kinase (JAK) inhibitors",
            "level5": "L01EJ02",
            "who_name": "fedratinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EJ",
            "level4_description": "Janus-associated kinase (JAK) inhibitors",
            "level5": "L01EJ03",
            "who_name": "pacritinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EK",
            "level4_description": "Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors",
            "level5": "L01EK01",
            "who_name": "axitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EK",
            "level4_description": "Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors",
            "level5": "L01EK02",
            "who_name": "cediranib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EK",
            "level4_description": "Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors",
            "level5": "L01EK03",
            "who_name": "tivozanib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EL",
            "level4_description": "Bruton's tyrosine kinase (BTK) inhibitors",
            "level5": "L01EL01",
            "who_name": "ibrutinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EL",
            "level4_description": "Bruton's tyrosine kinase (BTK) inhibitors",
            "level5": "L01EL02",
            "who_name": "acalabrutinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EL",
            "level4_description": "Bruton's tyrosine kinase (BTK) inhibitors",
            "level5": "L01EL03",
            "who_name": "zanubrutinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EM",
            "level4_description": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors",
            "level5": "L01EM01",
            "who_name": "idelalisib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EM",
            "level4_description": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors",
            "level5": "L01EM02",
            "who_name": "copanlisib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EM",
            "level4_description": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors",
            "level5": "L01EM03",
            "who_name": "alpelisib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EM",
            "level4_description": "Phosphatidylinositol-3-kinase (Pi3K) inhibitors",
            "level5": "L01EM04",
            "who_name": "duvelisib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EN",
            "level4_description": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors",
            "level5": "L01EN01",
            "who_name": "erdafitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EN",
            "level4_description": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors",
            "level5": "L01EN02",
            "who_name": "pemigatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EN",
            "level4_description": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors",
            "level5": "L01EN03",
            "who_name": "infigratinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EN",
            "level4_description": "Fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitors",
            "level5": "L01EN04",
            "who_name": "futibatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX01",
            "who_name": "sunitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX02",
            "who_name": "sorafenib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX03",
            "who_name": "pazopanib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX04",
            "who_name": "vandetanib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX05",
            "who_name": "regorafenib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX06",
            "who_name": "masitinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX07",
            "who_name": "cabozantinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX08",
            "who_name": "lenvatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX09",
            "who_name": "nintedanib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX10",
            "who_name": "midostaurin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX11",
            "who_name": "quizartinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX12",
            "who_name": "larotrectinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX13",
            "who_name": "gilteritinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX14",
            "who_name": "entrectinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX15",
            "who_name": "pexidartinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX17",
            "who_name": "capmatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX18",
            "who_name": "avapritinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX19",
            "who_name": "ripretinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX21",
            "who_name": "tepotinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX22",
            "who_name": "selpercatinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01E",
            "level3_description": "PROTEIN KINASE INHIBITORS",
            "level4": "L01EX",
            "level4_description": "Other protein kinase inhibitors",
            "level5": "L01EX23",
            "who_name": "pralsetinib"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FA",
            "level4_description": "CD20 (Clusters of Differentiation 20) inhibitors",
            "level5": "L01FA01",
            "who_name": "rituximab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FA",
            "level4_description": "CD20 (Clusters of Differentiation 20) inhibitors",
            "level5": "L01FA02",
            "who_name": "ofatumumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FA",
            "level4_description": "CD20 (Clusters of Differentiation 20) inhibitors",
            "level5": "L01FA03",
            "who_name": "obinutuzumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FB",
            "level4_description": "CD22 (Clusters of Differentiation 22) inhibitors",
            "level5": "L01FB01",
            "who_name": "inotuzumab ozogamicin"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FB",
            "level4_description": "CD22 (Clusters of Differentiation 22) inhibitors",
            "level5": "L01FB02",
            "who_name": "moxetumomab pasudotox"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FC",
            "level4_description": "CD38 (Clusters of Differentiation 38) inhibitors",
            "level5": "L01FC01",
            "who_name": "daratumumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FC",
            "level4_description": "CD38 (Clusters of Differentiation 38) inhibitors",
            "level5": "L01FC02",
            "who_name": "isatuximab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FD",
            "level4_description": "HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors",
            "level5": "L01FD01",
            "who_name": "trastuzumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FD",
            "level4_description": "HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors",
            "level5": "L01FD02",
            "who_name": "pertuzumab"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FD",
            "level4_description": "HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors",
            "level5": "L01FD03",
            "who_name": "trastuzumab emtansine"
        },
        {
            "level1": "L",
            "level1_description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS",
            "level2": "L01",
            "level2_description": "ANTINEOPLASTIC AGENTS",
            "level3": "L01F",
            "level3_description": "MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES",
            "level4": "L01FD",
            "level4_description": "HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors",
            "level5": "L01FD04",
            "who_name": "trastuzumab deruxtecan"
        }
    ],
    "page_meta": {
        "limit": 1000,
        "next": "/chembl/api/data/atc_class.json?limit=1000&offset=3000",
        "offset": 2000,
        "previous": "/chembl/api/data/atc_class.json?limit=1000&offset=1000",
        "total_count": 5265
    }
}
